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Nanomaterials offer many unique opportunities for the development of effective 
and rapid point-of-care (POC) devices to be exploited in many fields, including 
early diagnosis, health monitoring, and pollutant detection. In particular, gold 
nanoparticles (AuNPs) exhibit tuneable catalytic and plasmonic properties, which 
are key enabling tools to design and develop innovative detection schemes in 
several sensing applications. The aim of this PhD project was the development of 
AuNPs-based colorimetric POCs to detect heavy metal ion contaminations and 
specific biomarkers in non-invasive biological fluids. First, we developed a novel 
strategy that exploits the combination of the plasmonic and catalytic properties of 
AuNPs to achieve an ultrafast (1 min) and sensitive colorimetric sensor for highly 
toxic methyl mercury. Taking advantage of the AuNP nanocatalyst to promote the 
rapid reduction of methyl mercury with nucleation on the particle surface and 
consequent aggregation-induced plasmonic shift, we were able to detect by 
naked-eye mercury contaminations as low as 20 ppb, which is relevant for food 
contaminations or biological fluid assessment. Moreover, an innovative and 
versatile platform, based on multibranched AuNPs, was developed for the 
detection of salivary biomarkers. Coupling etching and growing reactions in a 
reshaping process onto the nanostars surface, we created a customizable platform 
with boosted colour change readout for fast detection of salivary glucose at low 
concentrations. The nanosensor performance was validated on samples from 
patients with diabetes, proving its potential as a novel non-invasive tool for 
frequent monitoring of glycaemia. As side project we also investigated the 
platinum nanoparticles enzymatic activity in a colorimetric sensor for mercury 






1.1 In vitro diagnostics  
 
Over last years, laboratory testing has been subjected to a continuous paradigm 
evolution to meet the increasing demand for high-qualitative healthcare and 
patient self-advocacy. The diagnostic concept is evolving rapidly, drawing the 
attention of both research and industry. We are witnessing the rapid development 
of next-generation in vitro diagnostic (IVD) devices, as result of an increasing 
competition between companies dragged by the rapid expansion of the global 
market (see Figure 1.1). The Food and Drug Administration (FDA) defined IVD 
products as “[...] those reagents, instruments, and systems intended for use in 
diagnosis of disease or other conditions, including a determination of the state of 
health, in order to cure, mitigate, treat, or prevent disease or its sequelae”1. 
Government agencies like FDA, or commissions, such as the European Commission 
(EC), drafted legislation to regulate the market, and, more importantly, to define 
and identify these new tools as a quality and safety standard for in vitro diagnostic 
medical devices2.  
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In vitro diagnostics provides useful solutions for analytical grade, qualitative and 
quantitative assessment of analytes in biological fluids or other complex samples.  
The detection of physio- and pathological biomarkers, like small molecules, 
steroids, and oligonucleotides, as well as food and environmental contaminants is 
the main purpose of IVD applications.  
Traditional IVD techniques, generally, require several operational steps, such as 
sample collection, delivery and treatment, target extraction and purification, 
which lead up the detection step. All these laborious and time-consuming 
procedures often necessitate specialized laboratories, costly reagents and 
instrumentations, and skilled personnel.  Moreover, in certain circumstances, a 
self-sampling is required, thus compelling unprepared users to invasive and 
painful sampling procedures. Due to these drawbacks, traditional diagnostics is 
becoming sub-optional. 
 
1.2 From IVDs to Point-Of-Care diagnostics 
 
The ageing population and the increasing incidence of chronic diseases necessitate 
high-quality healthcare, rapid and easy-to-use original solutions. Moreover, as 
recent events connected to pandemia have highlighted, the access to treatment 
and services has proved to be more and more complicated. Most of the people 
have experienced a challenged healthcare system with overcrowded hospital and 
long waiting time. Thus, early clinical diagnostics is becoming an active part of 
medical evaluations and disease management3 from risk assessment to disease 
monitoring (see Figure 1.2). In this framework, point-of-care (POC) testing plays a 




Figure 1.2 The application of in vitro diagnostics in the delivery of healthcare (ref. 4). 
 
Accurate and fast results can considerably reduce the preanalytical treatment 
errors, enabling rapid triage, allowing clinicians to gain more control on medical 
decisions with a remarkable improvement of patients’ quality of life4, and also 
preventing critical patient disability and death5,6. Indeed, POC testing provide lab-
quality outcomes within minutes, accelerating clinical decisions. It has been 
calculated that POC diagnosis could lead to a reduction of 44% in hospitalization 
length and a consequent decrease of related risk of both adverse complications 
and healthcare associated infections7,8. In addition, it has been estimated a total 
laboratory cost savings of 8-20% for those organizations that implement POC 
testing9. Waiting time can be reduced by 46 minutes, saving €148 per patient10,11. 
All these benefits are promoting the POC testing deployment. Indeed, in 2019, the 
global market size of POCT was evaluated for $28.5 billion and it was expected to 
reach USD 46.7 billion by 2024 (CAGR of 10.4%)12,13. Beyond bedside benefits, 
POCT shows several advantages when compared with traditional IVDs.  
The World Health Organization (WHO) issued some guidelines for developing 
efficient POCT known as ASSURED that is the acronym for affordable, sensitive, 
specific, user-friendly, rapid/robust, equipment-free or minimal, and delivered to 












Figure 1.3 Comparison between centralized laboratory and POCT characteristics. 
 
POC diagnostics does not require complex instrumentation or equipped rooms; it 
allows fast and in situ detection of biological/chemical contaminants or health 
state assessment anytime and anywhere, drastically facilitating the access to 
healthcare. Thus, POC testing offers an efficient tool for routine analysis and 
preliminary checks, accelerating the early diagnosis with a related notable 
improving of the quality of life (see Figure 1.3).  Today, in a scenario of global 
pandemics, the value of a fast, effective POC testing for large-scale screening on 
the fight of virus spreading is undeniable. Alternative diagnostic methods are 
urgently required to alleviate the laboratory workload during SARS-CoV-2 
outbreak15,16.  
POC-device portability is a distinctive feature, and it is closely related with the 
sensing strategy and relative device design adopted. Colorimetric visual detection-
based strategies are the most exploited, since the test outcome consists  in a 
colour change in terms of hue or saturation and does not need for any 
instrumentation to be recognised in both threshold and quantitative assessment.   
Nanomaterials offer a clear edge on the design of a new generation of effective 
POC devices, thanks to a variety of features exploitable to set up miniaturized, 
automated, colorimetric nanobiosensor. Nanotechnology is recently sustained by 
and combined with microfluids that provide different solutions for sample 
handling or reagent mixing, using microchannels and material science to 
manipulate from micro- to picolitres of solutions in a reduced space. Lateral flow 
devices (see Figure 1.4) represent a great example in which microfluidic principles 
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combined with immune/chemical assays technology and nanoplasmonic results in 
on-site platform capable of accurate results17,18.  
By virtue of its versatile nature, lateral flow assays (LFAs) are widely employed in 
a number of sectors from food and environmental testing to pharma and animal 
and plant health. Moreover, LFAs are recently implemented in multiplexing to 
detect simultaneously the presence of multiple food contaminants or to carry out 
the diagnosis of several significant biomarkers, useful in case of small sample 
volume availability18,19.  
 
 
Figure 1.4 Typical lateral flow device for POC testing. 
 
Simultaneously, the mHealth (abbreviation for mobile health) is rapidly gaining 
ground as a sub-segment of eHealth20 (see Figure 1.5). Information and 
communication technologies (ICT) are revolutionizing the healthcare system 
transforming common electronic devices, such as smartphones, into medical 
devices to acquire, store and analyse data. The main mHealth advantages include: 
remote data collection and monitoring for improved diagnosis and patients follow 
up, disease and epidemic outbreak tracking, effective data driven approach to 
personalized medicine21–23. Several companies recently market products using 









A biosensor is a full-fledged analytical measurement system specifically designed 
for the assessment of biochemicals as oligonucleotides, proteins or other 
biomarkers. Such analytes are recognized by a bioreceptor, which is a biological 
system (such as antibody, cell parts, enzymes, oligonucleotide) that selectively 
interacts with the target, thus resulting in a biological signalling. Afterwards, the 
transducer element converts the bioanalyte-receptor interaction into a 
measurable electrochemical, optical, pyroelectric, or piezoelectric signal. Such 
signal is then processed and/or amplified by an amplifier/detector24,25 (see Figure 
1.6). An example of this system is the Bio-FET, a biosensor based on MOSFET 
(metal-oxide-semiconductor field-effect transistor, or MOS transistor) that is 





Figure 1.6 Nanobiensor operation principle (left), and an example of application of viral protein 
detection (ref. 27). 
 
A biosensor must meet some important requirements that include sensitivity, 
selectivity, reproducibility and stability.  The biosensor selectivity is the capacity 
to recognize specific targets in a complex sample matrix rich in interfering 
components. The sensitivity refers to the ability of the biosensor to produce a 
signal for small variations of analyte concentration. The reproducibility is the 
property to generate the same response to replicated experimental setup, and it 
is closely related to the stability that quantifies how much the environment 
perturbations, such as variations of temperature and/or pH, can affect the result. 
About the outcome, the indicators that define the analytical performance of a 
biosensor are the Limit-Of-Detection (LOD), Limit-Of-Quantification (LOQ) and the 
Limit-Of-blank (LOB). The LOB describes the highest noise (apparent analyte 
concentration) expected to be found in the replicated blank samples. The LOD 
indicates the minimum threshold value of analyte concentration detectable, and 
the LOQ “is the highest apparent analyte concentration expected to be found 
when replicates of a blank sample containing no analyte are tested.”28. These are 
the main features and performance indicators to define an impactful and effective 






1.4 Nanotechnology for biosensing applications 
 
The early diagnosis and the health condition monitoring, as well as the 
environmental pollutants detection are attracting growing attention from both 
industry and research. Although there is still a need for suitable tools to be applied 
in such fields, a new generation of biosensors have been designed for POC 
testing29, due to the gained knowledge and expertise in the field of 
nanotechnologies and to the possibility to synthesize smart nanomaterials with 
unique properties. Indeed, nanomaterial-based sensors have been shown to be a 
suitable choice for instrument-free and on-site diagnostic applications30,31.  
European Commission defines a nanomaterial as “a natural, incidental or 
manufactured material containing particles, in an unbound state or as an 
aggregate or as an agglomerate and where, for 50 % or more of the particles in 
the number size distribution, one or more external dimensions is in the size range 
1 nm - 100 nm”32 (see Figure 1.7). At the nanometric size, the particles show 
peculiar physical and chemical behaviours owed to the predominant quantum 
confinement phenomena and surface effects33,34. 
 
 
Figure 1.7 Length scale of the biological components and the nanomaterials (comparison). 
 
The quantum confinement effect refers to the energy levels and relative electronic 
distribution in the nanomaterial. At this size, the material relative band gap 
decreases while energy levels become discrete, unlike the bulk dimensions of the 
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same material35. The electron mobility is reduced at certain discontinuous energy 
states, phenomenon known as “quantum confinement”36. Therefore, the band 
gap shrinks or widens, following the nanoparticles size, with a relative increase or 
decrease of energy levels density (see Figure 1.8). Such renewed electronic 
configuration, typical of the nano-size, lends new properties to the particles as the 
way of interaction with light radiation, resulting in size and shape-dependent 
absorption and luminescence phenomena37,38. 
 
 
Figure 1.8 On the left graph of size to volume ratio correlation, on the right energy band gap in the 
nanocrystal semiconductor.  
 
Another important parameter influencing the nanomaterial surface properties is 
the high surface-to-volume ratio, which increases with the lowering of size39 (see 
Figure 1.8). Considering a generic sphere of radius r, its surface scale with the 
square of r while its volume with the cube of r, therefore, the ratio increases the 
particles size reduction. Paired the mass (in terms of  the number of atoms), the 
exposed surface grows extraordinarily. Even the surface reactivity is conditionated 
by the size. Given that the surface atoms are characterized by lower coordination 
number, resulting less stable than the more coordinated interior ones, the 
nanosized materials show a high surface energy40.  The latest developments in 
biosensor design have benefited from the size-dependent nanostructures 
properties to improve both the biorecognition interaction and the transducing 
reaction. On one hand, the high surface-to-volume ratio allows high reactivity to 
functionalization of the nanomaterial surface with bioreceptors, thus increasing 
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the specific target recognition reactions41,42. On the other, the catalytic properties 
of nanomaterials and their interaction with light can enhance the transducing 
process, enabling sensitive and colorimetric readout. Several nanomaterials have 
been exploited in hybrid nanosensors like carbon nanotubes, magnetic 
nanoparticles, silicon nanowires and nanostructured metallic particles (such as 
silver, gold, platinum, palladium and iron oxide). In particular, metallic 
nanoparticles exhibited high potentiality in several detection mechanisms43. These 
nanomaterials can be easily obtained following different chemical methodologies 
that enable an accurate control of size- and shape-dependent optical, electrical 
and catalytic properties44–46.  
 
1.5 Gold Nanoparticles POC Applications 
 
Among the metal nanomaterials, AuNPs present a series of peculiar features, 
which will be discussed in detail in the following paragraph, that make them 
particularly suitable for the development of colorimetric methods for POC 
applications in several fields, from environmental control to healthcare.  
1.5.1 Environmental pollutant assessment 
 
Most of the heavy metal ions are known to be highly toxic and in some cases 
carcinogens, and are considered as environmental health hazards to the extent of 
being ranked in the hazardous substances top ten47,48. In particular, mercury and 
organic mercury pollution is a global health threat given its well-documented toxic 
effect on living organisms and its widespread presence in the environment. The 
main sources of mercury contamination are coal power plants and metal mining 
that release more than one thousand metric tons per year49. Following this 
anthropogenic high emission, mercury is highly present in seawater and in soil, 
accumulate in aquatic species and enter the human food chain50. In the 
environment, mercury further reacts forming methylmercury through three 
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different ways, i.e. abiotic methylation, methylation by microorganism and photo 
methylation51(see Figure 1.9). Once ingested in the human gastrointestinal 
system, mercury and methylmercury (CH3Hg+) get adsorbed and have a half-life of 
70 days. 
 
Figure 1.9 Mercury is methylated in anoxic environments by microorganisms (illustration in the 
inset). The toxic methylmercury accumulates in aquatic species (bioaccumulation), and its 
concentrations increase with each trophic level (biomagnification) (ref. 51). 
CH3Hg+ is known to be much more toxic than inorganic one (Hg2+), as, due to its 
reactivity with the sulfhydryl group, it forms a glutathione conjugate that reaches 
different cell biochemical mechanism, causing DNA toxicity as a consequence of 
increased global and gene-specific methylation. Moreover, it can pass the blood-
brain barrier thanks to its lipophilicity and, there, CH3Hg+ strongly inhibits 
astrocytic glutamate uptake. CH3Hg+ causes mitochondrial dysfunction and 
activation of cell death pathways, overactivating (NMDA) receptors, and, thus, 
increasing the Ca2+ influx into postsynaptic neurons. In addition, CH3Hg+ 
determines elevated ROS species generation (which increases the oxidative stress) 
and lipid peroxidation and, hence, the impairment of the activity of 
neurotransmitter and neuromodulator receptors52–55(see Figure 1.10).  The 






Figure 1.10 On the left the CH3Hg+ induced oxidative stress and Ca2+ and glutamate dishonesties, 
on the right CH3Hg+ effects on the GSH antioxidant system (ref. 55). 
 
In the human body, the major source of both organic and inorganic mercury is the 
consumption of contaminated food, in particular shellfish and large-size fish, like 
tuna and swordfish57–61. Considering the high risks involved with mercury 
contaminated food consumption, American and European authorities have set out 
rigid limits for methyl mercury concentration in food and water62. FAO and WHO 
organizations have established that the maximum levels of CH3Hg+ allowed in fish 
could not exceed 1.0 μg/g for predatory fish and 0.5 μg/g for other fishery 
products, calculated on the basis of wet weight63,64. To date, the detection and 
quantification of mercury species (Hg2+, CH3Hg+) are performed by a plethora of 
complex and costly laboratory-based methods65-69. Therefore, there is a strong 
need for portable and easy-to-use devices for the simple and rapid home testing 
of these threating pollutants. Harvesting the potential recently opened by the 
application of nanoparticles to analytic issues, several colorimetric nanosensors 
have been recently proposed for naked-eye detection of mercury70,71. However, 
the sensitivity and reliability are still a major challenge for routine monitoring 
application. Moreover, only few reports deal with the detection of organic 




1.5.2 Early diagnostic and health conditions 
monitoring 
 
The National Institutes of Health (NIH) defines a biomarker as an “objectively 
measured and evaluated indicator of normal biologic processes, pathogenic 
processes, or pharmacologic responses to therapeutic intervention”74. Biomarkers 
are biological molecules able to supply information concerning the physiologic 
state of a living organism. Variations of biomarker concentration, structure, and 
function can identify a progression or regression of a specific disorder or 
demonstrate how the body responds to it.  Evaluation and profiling of a biomarker 
is a useful tool to the health conditions monitoring, risk assessment and early 
diagnostic75.  
 
1.6 Saliva as diagnostic fluid 
 
Nowadays, different biological fluids like blood (gold standard), serum, urine, 
cerebrospinal fluid, sperm etc. are used as diagnostic tools, but they need 
particular precautions and skilled personnel to be collected with few 
complications76,77. Besides, traditional biological fluids (e.g. blood) require invasive 
sampling techniques like painful finger pricking that entail evident discomfort and 
health risks, such as infections and viral transmission. Hence, there is an increasing 
attention towards non-invasive sampling. In this context, the use of saliva as 
diagnostic fluid is becoming a clinical reality75,78,79. 
Saliva is a colourless, pseudo acidic, muco-serous exocrine secreted fluid. Whole 
saliva is a mixture from parotid (20–25% of secretion), submandibular (70–75% of 
secretion), sublingual, tubarial and minor glands. Main constituents include water 
(98%), mucopolysaccharides and glycoproteins, electrolytes, white blood cells, 
epithelial cells (DNA vehicle), proteins and enzymes like amylase lipase and 
antimicrobial enzyme. The daily production of saliva ranges from 0.5 to 1.5 litres, 
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its normal flow rate is about 0.3 mL/min and it increases up to 7 mL/min when 
stimulated. The resting pH varies from 6.2 to 7.4, and this value changes with a 
meal (it increases within 5 minutes after the intake of food, and returns to basal 
levels approximately 15 minutes after food consumption)75,80,81. 
 
Figure 1.11 On the left, salivary glands location; in magnified, view of the duct and the acinar 
structures. On the right, representative biomarkers of salivary fluids. 
 
Saliva contains a variety of molecules representative of the entire spectrum of 
normal or pathological conditions (see Figure 1.11). In human saliva are secreted 
endogenous substances at relative tissue concentrations, as well as molecules 
used for recreational purposes or therapy and markers of hormonal, 
immunological status, neurological and metabolic conditions.   
Salivaomics is a term introduced in 2008 consequentially to the rapid development 
of knowledge on -omics salivary constituents82–84. To date, there are five major 
salivary diagnostic elements such as proteome, microbiome, transcriptome, 
micro-RNA, and metabolome to classify the salivary constituents as biomarkers. 
Most common and abundant salivary substances with clinical relevance (validated 
biomarkers) include microparticles, viruses, bacteria, various proteins, immune 
system complement as IgA, IgG, IgM, polynucleotides, lipids like cholesterol and 
triglycerides, steroid hormones, electrolytes and small signalling molecules75,85.     
Human saliva shows another tempting quality: it can be quickly and easily 
collected without training86,87.  
A relevant limitation to the use of saliva in diagnostics concerns the analyte 
concentration, as they are generally present in lower percentage than in serum. 
Such issue inevitably calls for a new generation of sensitive diagnostic methods to 
be designed. Despite the variety of nanoparticle-based colorimetric detection 
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mechanisms reported in the literature, no one of these can be effectively used to 
detect salivary biomarkers.  
 
1.6.1 Salivary glucose as biomarker  
 
Type 1 diabetes is a chronic autoimmune condition caused by the pancreas 
reduced (or absent) insulin production with unknown causes and without no way 
to prevent. Type 2 diabetes is a chronic progressive pathology with gradually loss 
of the ability to secrete sufficient insulin. Diabetes is frequently caused by lifestyle 
factors (obesity lacking physical activity), even if genetics also plays an important 
role, in fact in Asian populations type II diabetes  is described as an “epidemic”88,89. 
Diabetes is constantly increasing impact on the population. From 2000 to 2016 
there was a 6.8% increase of premature deaths (3.96 million in the age group 20-
79 year) for diabetes; in 2014, more than the 8.5% of 18 aged adults was diagnosed 
with diabetes. Although the blood can be considered as the gold standard fluid for 
the disease diagnosis and monitoring, the associated risk of exposure to infections, 
the difficulties of sampling from children and/or chronically ill patients, can heavily 
affect compliance, strongly discouraging this kind of tests90–93.   
Self-monitoring glucose is a basic, routine procedure for diabetic patients. 
Education programs promote this practice emphasising the correct disposal of 
needles to avoid contaminations other than transmission of blood borne viruses94. 
However, despite the carefulness, hepatitis outbreaks have been reported in 
settings where multiple patients with diabetes undergo self or assisted monitoring 
of blood glucose. United States investigated 18 types of hepatitis B virus (HBV) 
infection outbreaks (1990-2008) associated with the improper use of blood 
glucose monitoring equipment95. 
Since glucose level is challenging to monitor and patients spend considerable 
periods in hyperglycaemic conditions (outside target range), an intensive insulin 
administration is often correlated with death, while more frequent glycaemic 
assessments reduce mortality and morbidity in critical ill persons, improving 
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observed beneficial outcome96,97. Regular glycaemia self-monitoring helps people 
to handle diabetes understanding the impact of food intake, sport activity, stress, 
illness etc. on their glucose levels. Frequent self-monitoring allows people to 
maintain an appropriate quality of life, and to adjust medications improving long-
term health outcomes. This results into a reduced risk of diabetes-related 
complications (heart attack, stroke and irreversible damage to eyes, kidneys and 
nerves)96,98,99. There are several devices currently available to monitor glucose 
levels reported in Table 1.1 and classified into three main categories.  
 
 
Table 1.1 Risks and difficulties with available invasive glucose monitoring devices for people with 
diabetes (ref. 100). 
 
Self-monitoring blood glucose (SMBG) devices are the most affordable but also 
painful and costly. Continuous glucose monitoring (CGM) and flash glucose 
motinoring (FGM) devices offer a convenient option, even if the complexity of 
these technologies can be a restriction as the skin penetration entails a risk of pain, 
reactions, allergies and infections100–102. In this context, the use of saliva as 
biological source is attracting great interest from POC testing community to 
develop novel methods for glucose levels self-monitoring. Several studies report a 
good correlation between the blood glucose levels and the salivary ones. Despite 
the quantity of data, the literature is contradictory since several parameters affect 
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the salivary glucose values, most of which related to the collecting protocol and 
the subject group enrolment criteria used for the studies. However, P. Balanet 
al.103 found that salivary glucose levels are significantly higher in uncontrolled 
diabetic subjects (13.35 ± 6.61 mg/dl) and controlled diabetic subjects (4.95 ± 
2.479 mg/dl) than in nondiabetic subjects (1.18 ± 0.675 mg/dl), in accordance with 
previous studies104,105. Likewise, other works reported a remarkable correlation 
with variable ratios from 1:40 to 1:100 depending on the considered population 
(healthy or diabetic, age, body mass index etc.)106–108 (see Figure 1.12 and 1.13). 
 
  
Figure 1.12 On the left, representative salivary-blood glucose level correlation (ref. 109). On the 
right, comparison of salivary and serum components in diabetes type II (above) and comparison 
between diabetic (group I) and non-diabetic (group II) persons (below).  
 
 
Figure 1. 13 Contrast of glucose concentrations in different physiological fluids between healthy 
and diabetic people108. 
 
Researchers have been attempting for several years to design functional 
commercial non-invasive glucose measurement devices. There are several 
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challenges associated with non-invasive monitoring and many factors that 
participate to inaccurate result readings. Sensitivity, selectivity and interferences 
represent the main obstacles even due to the limitations in hardware and software 
state of the art. Nevertheless, thanks to the new technologies and the continuous 
improvements, the appearance of novel and effective non-invasive glucose sensor 
is only a matter of time109. 
 
Figure 1.14 (A) Technologies under development for minimally invasive and non-invasive glucose 
detection; (B) block diagram of the device for glucose measurement with finger-pricking method; 
(C) principle of optical polarimetry in the eye for glucose monitoring 110. 
 
1.7 Gold nanoparticles for nanobiosensor 
 
1.7.1 Introduction to gold nanoparticles  
 
The significant developments in microfabrication techniques have inspired the 
design of a new generation of metal-nanoparticle based sensors, which exploit the 
interesting physicochemical properties of such nanosized materials. Among them, 
gold nanoparticles (AuNPs) have revealed attractive tools to fabricate rapid and 





properties, and their easy preparation. High quality AuNPs can be rapidly 
synthesized by several standardized physical (laser ablation microwave and 
ultraviolet irradiation), chemical, and biological methods110. The most widely used 
is the wet chemical reaction111,112 that produces stable AuNPs in aqueous medium. 
AuNP stability is a crucial factor for their applicability, and it is generally provided 
by a shell of charged capping agents, like trisodium citrate or 
cetyltrimethylammonium bromide (CTAB). Such array lends an electrical double 
layer (EDL), so that AuNPs undergo an electrostatic repulsion that prevents their 
aggregation and confers colloidal stability, according to the principles of 
Derjaguin–Landau–Verwey–Overbeek (DLVO) theory113–116 (see Figure 1.15). 
Typically, particle stability is quantified by measuring the zeta potential values that 
correspond to the electrical potential at the external interface of the EDL. 
Nanoparticle solutions that present zeta potential lower than – 25/30 mV o higher 
than 25/30 mV have great colloidal stability, enough to remain stable 
(monodispersed particles) in solution for desired applications117. Nanoparticle 
environmental changes, such as the displacement of weakly bound capping 
agents, strongly affect both the Stern layer and the outer diffuse layer that show 




Figure 1.15 (A) Formed electrical double layer (EDL) which consists of the inner Stern layer and the 
outer diffuse layer; (B) corresponding decrease in the counter- and co-ion concentrations with 
respect to the distance from the particle surface; (C) plotting of the EDL, van der Waals and total 




The salt-induced aggregation is a well-known process in which the increased ionic 
strength of the solution makes the AuNPs thermodynamically unstable 
culminating in the diffusion-limited cluster aggregation or the reaction-limited 
cluster aggregation. To increase the nanoparticle stability and to assign bio-
recognizing features at the same time, AuNP capping agents can be chemically 
substituted with several functional groups like protein, polymers and 
oligonucleotides. The peculiar physical and optical properties have rendered 
AuNPs suitable candidates to develop nanobiosensor that promise to be more 
sensitive, specific, and rapid compared to the conventional biochemical 
assays119,120.  
 
1.7.2 Gold nanoparticles properties  
 
While bulk gold has a familiar yellow color in reflected light, thin Au films look blue 
in transmission and this blue color gradually changes through several tones of 
purple and red as the particle size is reduced to the nanometer range. This 
interesting optical behavior is due to a phenomenon known as Localized Surface 
Plasmon Resonance (LSPR)118,119.  
 
Figure 1.16 Schematic illustration of the resonant oscillation of conduction electrons in metal 
nanoparticles, which is responsible for the Localized Surface Plasmon Resonance (LSPR) 
phenomenon. 
When electromagnetic radiation hits the particles, the conduction electrons 
respond with a collective oscillation (surface plasmon) at a certain frequency 
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(plasmon frequency), determined by parameters such as material, shape, size and 
dielectric constant of the environment37 (see Figure 1.16).  
 
Figure 1.17 (A) Gold nanoparticle size dependant surface plasmon resonance; (B) colour shifting of 
various monodispersed colloidal gold nanoparticles 124-126. 
  
When the frequency of the incident radiation matches the frequency of the 
particle electron cloud, there is a resonant interaction resulting into a great light 
scattering and an optical absorbance, with absorption peaks corresponding to the 
plasmon frequency123. For AuNPs such plasmon frequency interests the visible 
range of the electromagnetic spectrum, resulting in intensely coloured 
suspensions (see Figure 1.17) visible by visual inspection121,122. 
Moreover, AuNPs are endowed with an extinction coefficient that is three to five 
orders of magnitude higher than the brightest molecular dye, inducing a visible 
colour even at pM concentrations. Importantly, such optical features can be tuned 
by controlling the structure of AuNPs in terms of shape, size, inter-particle distance 
and environmental shell.  
For instance, according to Gan theory124,125, by changing the AuNP shape from 
spheres to rods, the plasmon band splits into two bands, one of which in NIR 
region (corresponding to electron oscillations along the long axis, referred to 
longitudinal band), and the other one in the visible region at a wavelength similar 
to that of gold nanospheres. To date, there are several methods reported to 
prepare various crystalline geometries such as wet chemical growing, e-beam 
coating or chemical etching. Among the available structures (nanorods, 
nanotriangles,  nanocubes, bipyramid, and nanoshells)126,127, multibranched (MB, 





stronger than the one of spherical nanoparticles (as confirmed by surface-
enhanced Raman scattering and surface-enhanced fluorescence measurements), 
other than for the ability to synthetically fine-tune the shape128.  
The sharp and long edges of such nanocrystals result in an effective 
electromagnetic hot spot with related red-shift of the resonance peak due to the 
size effect. As the tip diameter increases, the inter-particle distance and the 
relative electric field increase too, while the attraction becomes weaker122,129. 
Consequently, the electric dipole oscillation period increases, and the resonance 
peak moves to lower frequencies (Figure 1.18A)129. The same red-shift of the LSPR 
is observed when increasing the number of tips (Figure 1.18B). In this case, a range 
of frequencies in the visible and near-IR can be covered by tuning MB-AuNP size 
and shape.130  
 
Figure 1. 18 (A) Resonance spectrum of multibranched gold nanoparticles with different tip 
length129; (B) absorption cross sections for Au nanostars with different number of tips from along 
with that for the equivalent Au nanosphere 134. 
 
Concerning the synthesis, there are several published methods to produce 
branched gold nanoparticles that require surfactants such as polymers, 
biomolecules or ions (cetyltrimethylammonium bromide, CTAB; 
polyvinylpyrrolidone, PVP, silver nitrate, AgNO3 etc.) acting as shape-directing 
agents in seed-mediated approaches131,132.  These molecules can strongly adsorb 
onto the nanocrystal surface, poisoning the reactivity. An interesting synthetic 




sulfonic acid) to obtain a complete set of MB-AuNPs, tuning the nanostructuration 
during the anisotropic seeded growth (Figure 1.19)128. 
 
 
Figure 1.19 (A) and (B) UV-Vis spectra of the 40 and 60 nm Au MBNPs, grown in the presence of 
different concentrations of HEPES. The increasing SPR redshift is also observable by a 
representative photograph of Au MBNPs (C) and (D)132. 
 
AuNP  property portfolio also includes remarkable catalytic activity in several 
reducing and oxidating reactions133–135. Common catalysed reactions include the 
thermal cis-trans isomerization, CO oxidation, cyclotrimerization, selective 
hydrogenations of nitro compounds, aldehydes, ketones etc. (Figure 1.20 A)136. 
Furthermore, recently, it has been reported that AuNPs can display enzymatic 
properties, being capable to mimic enzymatic activities such as reductase, glucose 
oxidase, peroxidase, catalase, superoxide dismutase and oxidase136,137. Several 
studies explored the dependence of AuNP catalytic properties according to their 
size and shape, and, in particular, they reported that a size reduction correspond 
to higher catalytic activity since the exposed surface is proportional to the activity 








1.7.3 Gold nanoparticle synthesis 
 
AuNPs can be easily prepared by wet chemical synthesis that involves the 
reduction of gold ions by the use of chemical reductants139. Turkevich first 
reported the method to produce AuNP colloidal suspension by a single-step 
reduction process of (AuCl4−) using sodium citrate as the reducing agent 




Figure 1.20 (A) Summary of the different AuNPs catalytic activities with representative examples; 
(B) comparison of the catalytic efficiency for the peroxidase-like activity of different-shaped and 
different-sized AuNPs. Horseradish peroxidase (HRP), their biological counterpart, is also included 
in the graph; (C) peroxidase-like activity of AuNP dependence on different surface modifications, 
measured as its catalytic efficiency 140. 
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Other common reductants include ascorbic acid, tannic acid, molecular hydrogen, 
hydrazine etc. In any case, the colloidal stabilization phase, by means of capping 
agents, is fundamental for a successful synthesis141,142. There are a number of 
advantages in using the chemical reduction protocol to synthesize AuNPs. Wet 
chemical processes are simple, produce metal nanocrystal closely similar in size 
and stable; the protocol is simple to scale-up and reproducible115,143.  
 
Figure 1.21 Schematic representation of the generalized mechanism of nanoparticle growth due 
to coalescence 148. 
 
Briefly, a source of Au3+ (such as tetrachloroauric acid, HAuCl4), is boiled and 
reduced to metallic gold (Au0) adding trisodium citrate. These activated atoms 
start the nucleation step, leading to a 15 nm well-dispersed AuNPs that are 
stabilized by trisodium citrate (Figure 1.21). This protocol has been optimized 
adjusting HAuCl4/citrate ratio, temperature and pH value in order to improve 
AuNP monodispersion in size and shape. 35 nm spherical AuNPs are, then, 
synthetized using the 15 nm seeds and following the seeded growth approach, 
which exploits the property of the reducing agent hydroxylamine to quantitatively 
and selectively reduce Au3+ to elemental metal on the Au seeds surface143,144.    
 
 
1.7.4 Gold-nanoparticle based colorimetric 
strategies  
 
Among the available tools, the colorimetric nanobiosensors are the favourite 
methods for the design of POC devices for diagnosis and health condition 
assessment, environmental control, pollution monitoring and food analysis. 
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AuNPs exhibit certain properties as the strong LSPR in the visible region (and high 
extinction coefficients) and the enzymatic-like activity, which can be exploited to 
develop rapid, low-cost, and sensitive colorimetric sensors that allow clear and 
easy-to-interpret results. Therefore, the most studied gold-nanoparticle based 
colorimetric methods145 include aggregation-, growth-, etching- and nanozyme-
based mechanisms as summarized in Figure 1.22. 
 
 
Figure 1.22 Summary of different types of gold-nanoparticle based colorimetric sensors (ref. 150). 
 
Among the AuNP based methods, one of the most popular and diffused 
colorimetric sensing strategy is the controlled nanoparticle aggregation. This 
approach relies on a decrease in distance between nearby particles that results in 
a plasmon coupling effect and related colour shift. Such approach has become 
dominant in the field of colorimetric sensors since it requires a simple design and 
exhibits a high sensitivity146. 
As reported in Figure 1.23, the labelled methods relies on the use of AuNP-probes, 
meaning AuNPs functionalized with ligands such as DNA, antibodies or peptide. 
These chemically modified AuNPs have higher inter-particle repulsions and result 
to be more stable in high ionic strength environments than bare AuNPs, which 





































can be achieved by crosslinking, non-crosslinking, or destabilization 
aggregation147,148. In the first approach, the crosslinker plays a crucial role, as it 
induces the aggregation through several mechanism. For instance, if the 
crosslinker is a small molecule that can be activated or suppressed, the AuNP 
aggregation ca be easily controlled by regulating the linker state.  
 
Figure 1.23 Typical strategies of colorimetric detection mechanism based on gold nanoparticles 
plasmonic shifting (ref. 151). 
 
Another mechanism exploits the complementarity of oligonucleotides. An 
example was reported to detect Hg2+, using the thymine-Hg2+-thymine 
coordination chemistry and ssDNA-AuNP probes149. Hg2+ forms stable T-Hg2+-T 
base pairs and increases the Tm value, thus inducing the complementary 
hybridization of ssDNA onto the AuNPs (see Figure 1.24 A). Similarly, using the 
crosslinking approach, Retout et al.150 developed a rapid method for the detection 
of MDM2 oncoprotein (p53- and p14-binding protein with regulating functions). 
The AuNPs were functionalized with p53 and p14 proteins. In the presence of 
MDM2, the formation of a ternary complex (p53-MDM2-p14) caused the AuNP 






Figure 1.24 (A) Colorimetric detection of mercuric ion (Hg2+) using DNA–Au NPs (ref. 154); (B) 
detection of MDM2 using two peptide aptamer- functionalized AuNPs. The aggregation of the 
AuNPs was driven by the formation of a ternary complex of Mdm2, p53, and p14 (ref. 155). 
 
The non-crosslinking approach deals with a spontaneous aggregation of AuNPs 
due to a destabilizing event. For instance, dsDNA-AuNP complexes are less stable 
in an aqueous medium than ssDNA-AuNP system, because the fully matched 
duplex reduces the repulsive interactions. Such strategy was successfully applied 
in the colorimetric detection of various targets, and some modifications in the 
mechanism were introduced to improve the dsDNA–AuNP method sensitivity.151.  
In the destabilization-induced aggregation strategies, AuNPs aggregate by cleaving 
partially or totally the ligand that provides their electro/steric stabilization. 
Pathogenic bacterial DNA can be detected by RNAse H-controlled aggregation of 
RNA-functionalized AuNPs. RNA ligand was cleaved by RNAse H with simultaneous 
DNA–RNA hybridization (see Figure 1.25) 152. Another example of this approach 
uses aptamers that are oligonucleotides designed to have an affinity for a 
particular analyte, such as proteins, ions and small molecules153. These short 
sequences of nucleotides are adsorbed onto the AuNP surface that is stabilized. In 
the presence of the analyte, the aptamers leave the AuNP surface, determining a 







Figure 1.25 The RNAse H enzymatic cleavage in combination with DNA-RNA hybridization provides 
a highly specific and ultra-sensitive assay for the detection of DNA (ref. 157). 
 
Despite these strategies have revealed effective and easy to be designed, they 
show mainly two problems: the generation of false positive/negative, due to an 
unspecific aggregation induced by several factors like solvent, pH, temperature, 
ions, or molecules; the complex modification of the linker molecules onto the 
nanoparticles.  
Recently, a new class of nanosensors were developed, based on the enzymatic or 
chemical growth of small AuNPs on catalytic seeds. On the base of the principle 
for which hydrogen peroxide can be used as the reductant for AuNP growth, a 
colorimetric sensor for metal ion detection was developed154.  For instance, Zhou 
and Ma reported an assay for the detection of mercury ions155. In particular, in the 
absence of Hg2+ ions, gold nanoclusters (AuNCs) catalysed H2O2 chemical 
dissociation and the Au crystal growth kinetics was slow. Otherwise, in the 
presence of Hg2+ ions, AuNC catalytic activity was inhibited toward H2O2 and the 
Au3+ reduction occurred at a fast rate, and non-aggregated AuNPs were grown.  
In parallel to the growth methods, a new group of colorimetric methods is 
emerging156.  Several AuNPs, from gold nanospheres to gold nanorods (AuNRs) 
and nanotriangles, are exploited in etching-based sensors. The etching process 
consists of a shape reduction and a size modification of the nanoparticles with 
corresponded LSPR shift. The use of etchants agents as H2O2 and halogen ions can 
preferentially etch the AuNR terminals, leading to a lower aspect ratio or spherical 
AuNPs157. AuNR etching by H2O2, as reported, shows several drawbacks in the 
reaction conditions, because the high concentration of H2O2 and the harsh 
conditions in terms of temperature and pH, may limit the suitability of this system 
for sensing purposes.  
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The introduction of catalytic agents such as metal ions and enzymes could 
overcome this issue with fast reaction kinetics. Therefore, fast and sensitive 
methods were reported in the literature, based on Fenton-like o horseradish 
peroxidase (HRP) catalysed etching158 (see Figure 1.26 A). In the same way, the 
halide ions were used to increase the oxidative etching of AuNRs, promoting the 
solubility of gold monoxide. For example, the colorimetric detection of molybdate 
was optimized using the iodine-mediated etching method159 (see Figure 1.26 B). 
H2O2 could oxidize I− to I2 that can corrode CTAB, the stabilizer for AuNRs in acid 
condition. Such reaction could be accelerated adding molybdate that promote the 
reaction between H2O2 and I−157,160.  
 
 
Figure 1.26 (A) The aspect ratios of AuNRs gradually decrease with the increase of TMB2+, and the 
solution displays a colourful transition163; (B) colorimetric detection of molybdate based on 
catalytic etching of AuNRs164. 
 
In addition to the plasmonic properties, AuNPs are known to be effective as 
nanozymes, metal nanoparticles able to catalyse several reactions in strong, non-
physiological conditions. Charged AuNPs can greatly promote the oxidation of the 
substrate 3,3,5,5-tetramethylbenzidine (TMB) in the presence of H2O2 to generate 
a characteristic blue coloured solution. Thus, TMB chromogenic oxidation reaction 
can be used to enhance the output of several recognition mechanism145. For 
example, Jiang et al. demonstrated that chitosan-functionalized AuNPs showed 
higher peroxidase-like activity than the one exhibited by natural enzymes161. In 
another work, Kwi Nam Han et al. proved that Hg2+ could boost the catalytic 




increasing the activity on TMB oxidation reaction162 (see Figure 1.27 A). Wu et al. 
synthesized 2,6-diaminopurine (DAP)-capped AuNPs that responded to the 
presence of Fe2+ with an increased peroxidase-like activity163 (see Figure 1.27 B). 
A sensitive Fe2+ sensor was optimized for the assessment of both haemoglobin HB 
and red blood cells RBCs in urine samples. 
 
Figure 1.27 (A) Schematic illustration of the colorimetric PAD sensing mechanism for Hg2+ ions based 
on the mercury-promoted nanozyme activity of AuNPs (ref. 167); (B) the molecular structure of 
purine derivatives and the peroxidase like activity process of the AuNPs 168. 
 
Shah et al. studied how the adenosine triphosphate (ATP) could promote the 
peroxidase-like activity of citrate-capped AuNPs and developed a nanosensor to 
detect ATP molecules164. These approaches extremely reduce the costs, 
simplifying the procedures and shortening the execution time. Moreover, these 
assays are suitable for smartphone-based devices, smart platform to detect, 
transduce and analyse data in short time. Nevertheless, there are still critical 
issues that need to be solved for effective applications in real sample testing for 









1.8 Bibliography  
 
1. CFR - Code of Federal Regulations Title 21. 
2. EUR-Lex - 32017R0746 - EN - EUR-Lex. Available at: https://eur-
lex.europa.eu/eli/reg/2017/746/oj. (Accessed: 21st January 2021) 
3. Beeler, J. F. Development and Commercialization of In Vitro Diagnostics: Applications for 
Companion Diagnostics. in Biotechnology Entrepreneurship: Starting, Managing, and 
Leading Biotech Companies 331–340 (Elsevier Inc., 2014). doi:10.1016/B978-0-12-
404730-3.00024-5 
4. Rooney, K. D. & Schilling, M. M. Point-of-care testing in the overcrowded emergency 
department - Can it make a difference? Crit. Care 18, (2014). 
5. Parco, S., Visconti, P. & Vascotto, F. Hematology point of care testing and laboratory 
errors: An example of multidisciplinary management at a children’s hospital in northeast 
Italy. J. Multidiscip. Healthc. 7, 45–50 (2014). 
6. Rothschild, J. M. et al. The Critical Care Safety Study: The incidence and nature of adverse 
events and serious medical errors in intensive care*. Crit. Care Med. 33, 1694–1700 
(2005). 
7. Cecconi, M. et al. Consensus on circulatory shock and hemodynamic monitoring. Task 
force of the European Society of Intensive Care Medicine. Intensive Care Med. 40, 1795–
1815 (2014). 
8. Sarr, M. G., Gott, V. L. & Townsend, T. R. COLLECTIVE REVIEW Mediastinal Infection after 
Cardiac Surgery. doi:10.1016/S0003-4975(10)62300-4 
9. Lee-Lewandrowski, E. et al. Implementation of a point-of-care satellite laboratory in the 
emergency department of an academic medical center: Impact on test turnaround time 
and patient emergency department length of stay. Arch. Pathol. Lab. Med. 127, 456–460 
(2003). 
10. Asha, S. E. et al. Impact from point-of-care devices on emergency department patient 
processing times compared with central laboratory testing of blood samples: A 
randomised controlled trial and cost-effectiveness analysis. Emerg. Med. J. 31, 714–719 
(2014). 
11. Schilling, U. M. Time is Money—the Economic Impact of Point of Care on the Emergency 
Department of a Tertiary Care University Hospital. Point Care J. Near-Patient Test. 
Technol. 13, 21–23 (2014). 
12. Global Point of Care (POC) Diagnostics Market 2019-2023| 10% CAGR Projection Over the 
Next Five Years | Technavio | Business Wire. 
13. Point-of-Care Diagnostics Market | Growing at a CAGR of 10.4% | MarketsandMarkets. 
Available at: https://www.marketsandmarkets.com/Market-Reports/point-of-care-
diagnostic-market-106829185.html. (Accessed: 21st January 2021) 
14. Wang, Y., Yu, L., Kong, X. & Sun, L. Application of nanodiagnostics in point-of-care tests 
for infectious diseases. Int. J. Nanomedicine 12–4789 (2017). doi:10.2147/IJN.S137338 
15. Tang, Y. W., Schmitz, J. E., Persing, D. H. & Stratton, C. W. Laboratory diagnosis of COVID-
19: Current issues and challenges. Journal of Clinical Microbiology 58, (2020). 
16. Li, Z. et al. Development and clinical application of a rapid IgM-IgG combined antibody 
test for SARS-CoV-2 infection diagnosis. J. Med. Virol. 92, 1518–1524 (2020). 
36 
 
17. Soh, J. H., Chan, H. M. & Ying, J. Y. Strategies for developing sensitive and specific 
nanoparticle-based lateral flow assays as point-of-care diagnostic device. Nano Today 30, 
100831 (2020). 
18. Kim, H., Chung, D. R. & Kang, M. A new point-of-care test for the diagnosis of infectious 
diseases based on multiplex lateral flow immunoassays. Analyst 144, 2460–2466 (2019). 
19. Shrivastava, S., Trung, T. Q. & Lee, N. E. Recent progress, challenges, and prospects of 
fully integrated mobile and wearable point-of-care testing systems for self-testing. 
Chemical Society Reviews 49, 1812–1866 (2020). 
20. Li, K. F. Smart home technology for telemedicine and emergency management. J. 
Ambient Intell. Humaniz. Comput. 4, 535–546 (2013). 
21. Vimarlund, V., Olve Nils-Goran, N. G., Scandurra, I. & Koch, S. Organizational effects of 
information and communication technology (ICT) in elderly homecare: A case study. 
Health Informatics J. 14, 195–210 (2008). 
22. Mujawar, M. A. et al. Nano-enabled biosensing systems for intelligent healthcare: 
towards COVID-19 management. Materials Today Chemistry 17, 100306 (2020). 
23. Ho, T.-B., Le, L., Tran Thai, D. & Taewijit, S. Data-driven Approach to Detect and Predict 
Adverse Drug Reactions. Curr. Pharm. Des. 22, 3498–3526 (2016). 
24. Malik, P. et al. Nanobiosensors: Concepts and Variations. ISRN Nanomater. 2013, 327435 
(2013). 
25. Debnath, N. & Das, S. Nanobiosensor: Current trends and applications. in 
NanoBioMedicine 389–409 (Springer Singapore, 2020). doi:10.1007/978-981-32-9898-
9_16 
26. Bergveld, P. The impact of MOSFET-based sensors. Sensors and Actuators 8, 109–127 
(1985). 
27. Nidzworski, D. et al. A rapid-response ultrasensitive biosensor for influenza virus 
detection using antibody modified boron-doped diamond. Sci. Rep. 7, 1–10 (2017). 
28. Armbruster, D. A. & Pry, T. Limit of blank, limit of detection and limit of quantitation. Clin. 
Biochem. Rev. 29 Suppl 1, S49-52 (2008). 
29. Syedmoradi, L. et al. Point of care testing: The impact of nanotechnology. Biosensors and 
Bioelectronics 87, 373–387 (2017). 
30. Liu, L., Hao, Y., Deng, D. & Xia, N. Nanomaterials-based colorimetric immunoassays. 
Nanomaterials 9, (2019). 
31. Quesada-González, D. & Merkoçi, A. Nanomaterial-based devices for point-of-care 
diagnostic applications. Chemical Society Reviews 47, 4697–4709 (2018). 
32. EUR-Lex - 32011H0696 - EN - EUR-Lex. Available at: https://eur-lex.europa.eu/legal-
content/EN/TXT/?uri=CELEX%3A32011H0696. (Accessed: 26th January 2021) 
33. Asha, A. B. & Narain, R. Nanomaterials properties. in Polymer Science and 
Nanotechnology 343–359 (Elsevier, 2020). doi:10.1016/b978-0-12-816806-6.00015-7 
34. Roduner, E. Size matters: Why nanomaterials are different. Chem. Soc. Rev. 35, 583–592 
(2006). 
35. Sumanth Kumar, D., Jai Kumar, B. & Mahesh, H. M. Quantum Nanostructures (QDs): An 
Overview. in Synthesis of Inorganic Nanomaterials 59–88 (Elsevier, 2018). 
doi:10.1016/b978-0-08-101975-7.00003-8 
36. Singh, M., Goyal, M. & Devlal, K. Size and shape effects on the band gap of semiconductor 
37 
 
compound nanomaterials. J. Taibah Univ. Sci. 12, 470–475 (2018). 
37. Kelly, K. L., Coronado, E., Zhao, L. L. & Schatz, G. C. The optical properties of metal 
nanoparticles: The influence of size, shape, and dielectric environment. J. Phys. Chem. B 
107, 668–677 (2003). 
38. Träger, F. Optical properties of nanoparticles. Applied Physics B: Lasers and Optics 73, 291 
(2001). 
39. Uglov, V. V., Doroshevich, I. L., Kvasov, N. T., Remnev, G. E. & Shymanski, V. I. On physical 
properties of nanoparticles: size effect and scale of nanoobjects. Phys. status solidi 13, 
903–907 (2016). 
40. Albanese, A., Tang, P. S. & Chan, W. C. W. The Effect of Nanoparticle Size, Shape, and 
Surface Chemistry on Biological Systems. Annu. Rev. Biomed. Eng. 14, 1–16 (2012). 
41. Edwards, K. A., Bolduc, O. R. & Baeumner, A. J. Miniaturized bioanalytical systems: 
Enhanced performance through liposomes. Current Opinion in Chemical Biology 16, 444–
452 (2012). 
42. Lei, J. & Ju, H. Signal amplification using functional nanomaterials for biosensing. 
Chemical Society Reviews 41, 2122–2134 (2012). 
43. Taton, T. A., Mirkin, C. A. & Letsinger, R. L. Scanometric DNA array detection with 
nanoparticle probes. Science (80-. ). 289, 1757–1760 (2000). 
44. Lee, K. S. & El-Sayed, M. A. Gold and silver nanoparticles in sensing and imaging: 
Sensitivity of plasmon response to size, shape, and metal composition. J. Phys. Chem. B 
110, 19220–19225 (2006). 
45. Alivisatos, P. The use of nanocrystals in biological detection. Nature Biotechnology 22, 
47–52 (2004). 
46. Malekzad, H., Sahandi Zangabad, P., Mirshekari, H., Karimi, M. & Hamblin, M. R. Noble 
metal nanoparticles in biosensors: Recent studies and applications. Nanotechnology 
Reviews 6, 301–329 (2017). 
47. Tchounwou, P. B., Yedjou, C. G., Patlolla, A. K. & Sutton, D. J. Heavy Metals Toxicity and 
the Environment. EXS 101, 133–164 (2012). 
48. Clarkson, T. W., Magos, L. & Myers, G. J. The Toxicology of Mercury — Current Exposures 
and Clinical Manifestations. N. Engl. J. Med. 349, 1731–1737 (2003). 
49. Kubáň, P., Pelcová, P., Margetínová, J. & Kubáň, V. Mercury speciation by CE: An update. 
Electrophoresis 30, 92–99 (2009). 
50. Hong, Y. S., Kim, Y. M. & Lee, K. E. Methylmercury exposure and health effects. J. Prev. 
Med. Public Heal. 45, 353–363 (2012). 
51. Poulain, A. J. & Barkay, T. Cracking the Mercury Methylation Code. Science (80-. ). 339, 
1280 LP – 1281 (2013). 
52. Farina, M. & Aschner, M. Methylmercury-Induced Neurotoxicity: Focus on Pro-oxidative 
Events and Related Consequences. in Advances in neurobiology 18, 267–286 (2017). 
53. Farina, M., Aschner, M. & Rocha, J. B. T. Oxidative stress in MeHg-induced neurotoxicity. 
Toxicol. Appl. Pharmacol. 256, 405–417 (2011). 
54. Aschner, M. & Syversen, T. Methylmercury: recent advances in the understanding of its 
neurotoxicity. Ther. Drug Monit. 27, 278–83 (2005). 
55. Farina, M., Rocha, J. B. T. & Aschner, M. Mechanisms of methylmercury-induced 




56. Mahaffey, K. R., Clickner, R. P. & Bodurow, C. C. Blood organic mercury and dietary 
mercury intake: National Health and Nutrition Examination Survey, 1999 and 2000. 
Environ. Health Perspect. 112, 562–70 (2004). 
57. Mania, M., Wojciechowska-Mazurek, M., Starska, K., Rebeniak, M. & Postupolski, J. [Fish 
and seafood as a source of human exposure to methylmercury]. Rocz. Panstw. Zakl. Hig. 
63, 257–64 (2012). 
58. Guerrini, L. et al. Chemical speciation of heavy metals by surface-enhanced Raman 
scattering spectroscopy: identification and quantification of inorganic- and methyl-
mercury in water. Nanoscale 6, 8368–8375 (2014). 
59. Sahuquillo, I., Lagarda, M. J., Silvestre, M. D. & Farré, R. Methylmercury determination in 
fish and seafood products and estimated daily intake for the Spanish population. Food 
Addit. Contam. 24, 869–876 (2007). 
60. Gosnell, K. J. & Mason, R. P. Mercury and methylmercury incidence and bioaccumulation 
in plankton from the central Pacific Ocean. Mar. Chem. 177, 772–780 (2015). 
61. Shipp, A. M. et al. Determination of a site-specific reference dose for methylmercury for 
fish-eating populations. Toxicol. Ind. Health 16, 335–438 (2000). 
62. Commission Regulation (EC) No 1881/2006  of   setting maximum levels for certain 
contaminants in foodstuffs  (Text with EEA relevance). 
63. Vieira, H. C., Morgado, F., Soares, A. M. V. M. & Abreu, S. N. Fish consumption 
recommendations to conform to current advice in regard to mercury intake. Environ. Sci. 
Pollut. Res. 22, 9595–9602 (2015). 
64. Nutrition, C. for F. S. and A. Metals - Mercury and Methylmercury. 
65. Hight, S. C. & Cheng, J. Determination of methylmercury and estimation of total mercury 
in seafood using high performance liquid chromatography (HPLC) and inductively coupled 
plasma-mass spectrometry (ICP-MS): Method development and validation. Anal. Chim. 
Acta 567, 160–172 (2006). 
66. Rodrigues, J. L., de Souza, S. S., de Oliveira Souza, V. C. & Barbosa, F. Methylmercury and 
inorganic mercury determination in blood by using liquid chromatography with 
inductively coupled plasma mass spectrometry and a fast sample preparation procedure. 
Talanta 80, 1158–1163 (2010). 
67. Yao, C.-H., Jiang, S.-J., Sahayam, A. C. & Huang, Y.-L. Speciation of mercury in fish oils 
using liquid chromatography inductively coupled plasma mass spectrometry. Microchem. 
J. 133, 556–560 (2017). 
68. Li, X. & Wang, Z. Determination of mercury by intermittent flow electrochemical cold 
vapor generation coupled to atomic fluorescence spectrometry. Anal. Chim. Acta 588, 
179–183 (2007). 
69. Aranda, P. R., Gil, R. A., Moyano, S., De Vito, I. & Martinez, L. D. Slurry sampling in serum 
blood for mercury determination by CV-AFS. J. Hazard. Mater. 161, 1399–1403 (2009). 
70. Chansuvarn, W., Tuntulani, T. & Imyim, A. Colorimetric detection of mercury(II) based on 
gold nanoparticles, fluorescent gold nanoclusters and other gold-based nanomaterials. 
TrAC - Trends in Analytical Chemistry 65, 83–96 (2015). 
71. Lou, T., Chen, Z., Wang, Y. & Chen, L. Blue-to-Red Colorimetric Sensing Strategy for Hg 2+ 
and Ag + via Redox-Regulated Surface Chemistry of Gold Nanoparticles. ACS Appl. Mater. 
Interfaces 3, 1568–1573 (2011). 
72. Chen, L., Li, J. & Chen, L. Colorimetric Detection of Mercury Species Based on 
39 
 
Functionalized Gold Nanoparticles. ACS Appl. Mater. Interfaces 6, 15897–15904 (2014). 
73. Aulsebrook, M. L., Watkins, E., Grace, M. R., Graham, B. & Tuck, K. L. Modified Gold 
Nanoparticles for the Temperature-Dependent Colorimetric Detection of Mercury and 
Methylmercury. ChemistrySelect 3, 2088–2091 (2018). 
74. Ilyin, S. E., Belkowski, S. M. & Plata-Salamán, C. R. Biomarker discovery and validation: 
Technologies and integrative approaches. Trends in Biotechnology 22, 411–416 (2004). 
75. Yoshizawa, J. M. et al. Salivary biomarkers: Toward future clinical and diagnostic utilities. 
Clinical Microbiology Reviews 26, 781–791 (2013). 
76. Peredy, T. R. & Powers, R. D. Bedside diagnostic testing of body fluids. American Journal 
of Emergency Medicine 15, 400–407 (1997). 
77. Gatti, R. et al. Cortisol assays and diagnostic laboratory procedures in human biological 
fluids. Clinical Biochemistry 42, 1205–1217 (2009). 
78. Ilea, A. et al. Saliva, a magic biofluid available for multilevel assessment and a mirror of 
general health-a systematic review. Biosensors 9, (2019). 
79. Malamud, D. Saliva as a Diagnostic Fluid. Dental Clinics of North America 55, 159–178 
(2011). 
80. Humphrey, S. P. & Williamson, R. T. A review of saliva: Normal composition, flow, and 
function. J. Prosthet. Dent. 85, 162–169 (2001). 
81. Graphics Inc, P. Saliva Composition and Functions: A Comprehensive Review. (2008). 
82. Shah, S. Salivaomics: The current scenario. J. Oral Maxillofac. Pathol. 22, 375 (2018). 
83. Wong, D. T. W. Salivaomics. J. Am. Dent. Assoc. 143, 19S-24S (2012). 
84. Koneru, S. & Tanikonda, R. Salivaomics - A promising future in early diagnosis of dental 
diseases. Dent. Res. J. (Isfahan). 11, 11–5 (2014). 
85. Zhang, L., Xiao, H. & Wong, D. T. Salivary Biomarkers for Clinical Applications. Mol. Diagn. 
Ther. 13, 245–259 (2009). 
86. Bellagambi, F. G. et al. Saliva sampling: Methods and devices. An overview. TrAC - Trends 
in Analytical Chemistry 124, 115781 (2020). 
87. Woo, J. S. & Lu, D. Y. Procurement, transportation, and storage of saliva, buccal swab, 
and oral wash specimens. in Methods in Molecular Biology 1897, 99–105 (Humana Press 
Inc., 2019). 
88. Ma, R. C. W. & Chan, J. C. N. Type 2 diabetes in East Asians: Similarities and differences 
with populations in Europe and the United States. Ann. N. Y. Acad. Sci. 1281, 64–91 
(2013). 
89. IDF Diabetes Atlas 9th edition 2019. Available at: https://www.diabetesatlas.org/en/. 
(Accessed: 28th January 2021) 
90. Shaw, J. E., Sicree, R. A. & Zimmet, P. Z. Global estimates of the prevalence of diabetes for 
2010 and 2030. Diabetes Research and Clinical Practice 87, 4–14 (2010). 
91. Roglic, G. & Unwin, N. Mortality attributable to diabetes: Estimates for the year 2010. 
Diabetes Research and Clinical Practice 87, 15–19 (2010). 
92. Tiongco, R. E., Bituin, A., Arceo, E., Rivera, N. & Singian, E. Salivary glucose as a non-
invasive biomarker of type 2 diabetes mellitus. J. Clin. Exp. Dent. 10, e902–e907 (2018). 
93. Gupta, S. et al. Correlation of salivary glucose level with blood glucose level in diabetes 
mellitus. J. Oral Maxillofac. Pathol. 21, 334–339 (2017). 
40 
 
94. Klonoff, D. C. & Perz, J. F. Assisted monitoring of blood glucose: Special safety needs for a 
new paradigm in testing glucose. Journal of Diabetes Science and Technology 4, 1027–
1031 (2010). 
95. Thompson, N. D. & Perz, J. F. Eliminating the blood: Ongoing outbreaks of hepatitis B 
virus infection and the need for innovative glucose monitoring technologies. J. Diabetes 
Sci. Technol. 3, 283–288 (2009). 
96. Van den Berghe, G. et al. Outcome benefit of intensive insulin therapy in the critically ill: 
Insulin dose versus glycemic control*. Crit. Care Med. 31, 359–366 (2003). 
97. Finney, S. J., Zekveld, C., Elia, A. & Evans, T. W. Glucose Control and Mortality in Critically 
Ill Patients. J. Am. Med. Assoc. 290, 2041–2047 (2003). 
98. Borus, J. S. & Laffel, L. Adherence challenges in the management of type 1 diabetes in 
adolescents: Prevention and intervention. Current Opinion in Pediatrics 22, 405–411 
(2010). 
99. Sørgård, B., Iversen, M. M. & Mårtensson, J. Continuous glucose monitoring in adults with 
type 1 diabetes: A balance between benefits and barriers: A critical incident study. J. Clin. 
Nurs. 28, 3318–3329 (2019). 
100. Hilliard, M. E. et al. Benefits and Barriers of Continuous Glucose Monitoring in Young 
Children with Type 1 Diabetes. Diabetes Technol. Ther. 21, 493–498 (2019). 
101. Engler, R., Routh, T. L. & Lucisano, J. Y. Adoption Barriers for Continuous Glucose 
Monitoring and Their Potential Reduction With a Fully Implanted System: Results From 
Patient Preference Surveys. Clin. Diabetes 36, 50–58 (2018). 
102. Addressing the Challenges of Invasive Glucose Monitoring. (2019). 
103. Balan, P. et al. Can saliva offer an advantage in monitoring of diabetes mellitus? - A case 
control study. J. Clin. Exp. Dent. 6, e335-8 (2014). 
104. Aydin, S. A comparison of ghrelin, glucose, alpha-amylase and protein levels in saliva from 
diabetics. J. Biochem. Mol. Biol. 40, 29–35 (2007). 
105. Carda, C., Mosquera-Lloreda, N., Salom, L., Gomez De Ferraris, M. E. & Peydró, A. A 
structural and functional salivary disorders in type 2 diabetic patients. Med. Oral Patol. 
Oral Cir. Bucal 11, 209–214 (2006). 
106. Srivastava, P., Agarwal, B. . & Chandel, M. S. A COMPARATIVE STUDY OF SERUM AND 
SALIVARY BIOCHEMICAL MARKERS IN DIABETES MELLITUS TYPE II WITH HEALTHY 
INDIVIDUALS. Int. J. Med. Biomed. Stud. 4, 161–164 (2020). 
107. Gupta, S. et al. Correlation of salivary glucose level with blood glucose level in diabetes 
mellitus. J. Oral Maxillofac. Pathol. 21, 334–339 (2017). 
108. Rp, A. et al. Noninvasive Method for Glucose Level Estimation by Saliva. J Diabetes Metab 
Cit. Agrawal RP 4, 266 (2013). 
109. Gonzales, W. V., Mobashsher, A. T. & Abbosh, A. The progress of glucose monitoring—A 
review of invasive to minimally and non-invasive techniques, devices and sensors. 
Sensors (Switzerland) 19, (2019). 
110. Singh, P. et al. Gold nanoparticles in diagnostics and therapeutics for human cancer. 
International Journal of Molecular Sciences 19, (2018). 
111. Low, A. & Bansal, V. A visual tutorial on the synthesis of gold nanoparticles. Biomed. 
Imaging Interv. J. 6, (2010). 
112. Lawrence, M., Testen, A., Koklic, T. & Smithies, O. A simple method for the size controlled 
synthesis of stable oligomeric clusters of gold nanoparticles under ambient conditions. J. 
41 
 
Vis. Exp. 2016, (2016). 
113. Park, J. W. & Shumaker-Parry, J. S. Structural study of citrate layers on gold nanoparticles: 
Role of intermolecular interactions in stabilizing nanoparticles. J. Am. Chem. Soc. 136, 
1907–1921 (2014). 
114. Park, J., Joo, J., Soon, G. K., Jang, Y. & Hyeon, T. Synthesis of monodisperse spherical 
nanocrystals. Angewandte Chemie - International Edition 46, 4630–4660 (2007). 
115. Polte, J. Fundamental growth principles of colloidal metal nanoparticles - a new 
perspective. CrystEngComm 17, 6809–6830 (2015). 
116. Al-Johani, H. et al. The structure and binding mode of citrate in the stabilization of gold 
nanoparticles. Nat. Chem. 9, 890–895 (2017). 
117. Majzik, A., Patakfalvi, R., Hornok, V. & Dékány, I. Growing and stability of gold 
nanoparticles and their functionalization by cysteine. Gold Bull. 42, 113–123 (2009). 
118. Pamies, R. et al. Aggregation behaviour of gold nanoparticles in saline aqueous media. J. 
Nanoparticle Res. 16, 1–11 (2014). 
119. Hutter, E. & Fendler, J. H. Exploitation of localized surface plasmon resonance. Adv. 
Mater. 16, 1685–1706 (2004). 
120. Peixoto de Almeida, M. et al. Gold Nanoparticles as (Bio)Chemical Sensors. in 
Comprehensive Analytical Chemistry 66, 529–567 (Elsevier B.V., 2014). 
121. Homola, J., Yee, S. S. & Gauglitz, G. Surface plasmon resonance sensors: review. Sensors 
Actuators, B Chem. 54, 3–15 (1999). 
122. Papavassiliou, G. C. Optical properties of small inorganic and organic metal particles. 
Progress in Solid State Chemistry 12, 185–271 (1979). 
123. Huang, X. & El-Sayed, M. A. Gold nanoparticles: Optical properties and implementations 
in cancer diagnosis and photothermal therapy. Journal of Advanced Research 1, 13–28 
(2010). 
124. Lee, K. S. & El-Sayed, M. A. Dependence of the enhanced optical scattering efficiency 
relative to that of absorption for gold metal nanorods on aspect ratio, size, end-cap 
shape, and medium refractive index. J. Phys. Chem. B 109, 20331–20338 (2005). 
125. Murphy, C. J. et al. Anisotropic metal nanoparticles: Synthesis, assembly, and optical 
applications. J. Phys. Chem. B 109, 13857–13870 (2005). 
126. Yaraki, M. T. & Tan, Y. N. Metal Nanoparticles‐Enhanced Biosensors: Synthesis, Design 
and Applications in Fluorescence Enhancement and Surface‐enhanced Raman Scattering. 
Chem. – An Asian J. 15, 3180–3208 (2020). 
127. Borzenkov, M., Chirico, G., Collini, M. & Pallavicini, P. Gold Nanoparticles for Tissue 
Engineering. in 343–390 (Springer, Cham, 2018). doi:10.1007/978-3-319-76090-2_10 
128. Maiorano, G. et al. Monodispersed and size-controlled multibranched gold nanoparticles 
with nanoscale tuning of surface morphology. Nanoscale 3, 2227–2232 (2011). 
129. Shan, F. & Zhang, T. Theoretical study on surface plasmon properties of gold nanostars. in 
IOP Conference Series: Materials Science and Engineering 322, 022005 (Institute of 
Physics Publishing, 2018). 
130. Rodríguez-Oliveros, R. & Sánchez-Gil, J. A. Gold nanostars as thermoplasmonic 
nanoparticles for optical heating. Opt. Express 20, 621 (2012). 
131. Senthil Kumar, P., Pastoriza-Santos, I., Rodríguez-González, B., Javier García De Abajo, F. 
& Liz-Marzán, L. M. High-yield synthesis and optical response of gold nanostars. 
42 
 
Nanotechnology 19, 015606 (2008). 
132. Sau, T. K. & Murphy, C. J. Room temperature, high-yield synthesis of multiple shapes of 
gold nanoparticles in aqueous solution. J. Am. Chem. Soc. 126, 8648–8649 (2004). 
133. Leyva-Pérez, A. et al. Reactivity of electron-deficient alkynes on gold nanoparticles. ACS 
Catal. 3, 1865–1873 (2013). 
134. Burch, R. Gold catalysts for pure hydrogen production in the water-gas shift reaction: 
Activity, structure and reaction mechanism. Phys. Chem. Chem. Phys. 8, 5483–5500 
(2006). 
135. Herzing, A. A., Kiely, C. J., Carley, A. F., Landon, P. & Hutchings, G. J. Identification of 
active gold nanoclusters on iron oxide supports for CO oxidation. Science (80-. ). 321, 
1331–1335 (2008). 
136. Lou-Franco, J., Das, B., Elliott, C. & Cao, C. Gold Nanozymes: From Concept to Biomedical 
Applications. Nano-Micro Letters 13, 1–36 (2021). 
137. Lin, Y., Ren, J. & Qu, X. Nano-gold as artificial enzymes: Hidden talents. Adv. Mater. 26, 
4200–4217 (2014). 
138. Stenlid, J. H. & Brinck, T. Extending the σ-Hole Concept to Metals: An Electrostatic 
Interpretation of the Effects of Nanostructure in Gold and Platinum Catalysis. J. Am. 
Chem. Soc. 139, 11012–11015 (2017). 
139. Alshammari, A. & Kalevaru, V. N. Supported Gold Nanoparticles as Promising Catalysts. in 
Catalytic Application of Nano-Gold Catalysts (InTech, 2016). doi:10.5772/64394 
140. Wuithschick, M. et al. Turkevich in New Robes: Key Questions Answered for the Most 
Common Gold Nanoparticle Synthesis. ACS Nano 9, 7052–7071 (2015). 
141. Daruich De Souza, C., Ribeiro Nogueira, B. & Rostelato, M. E. C. M. Review of the 
methodologies used in the synthesis gold nanoparticles by chemical reduction. Journal of 
Alloys and Compounds 798, 714–740 (2019). 
142. Iqbal, M. et al. Preparation of gold nanoparticles and determination of their particles size 
via different methods. Mater. Res. Bull. 79, 97–104 (2016). 
143. Thanh, N. T. K., Maclean, N. & Mahiddine, S. Mechanisms of nucleation and growth of 
nanoparticles in solution. Chemical Reviews 114, 7610–7630 (2014). 
144. Turkevich, J. Colloidal gold. Part I - Historical and preparative aspects, morphology and 
structure. Gold Bull. 18, 86–91 (1985). 
145. Chang, C. C. et al. Gold nanoparticle-based colorimetric strategies for chemical and 
biological sensing applications. Nanomaterials 9, (2019). 
146. Chen, H., Zhou, K. & Zhao, G. Gold nanoparticles: From synthesis, properties to their 
potential application as colorimetric sensors in food safety screening. Trends in Food 
Science and Technology 78, 83–94 (2018). 
147. Fujita, M. et al. Structural study on gold nanoparticle functionalized with DNA and its 
non-cross-linking aggregation. J. Colloid Interface Sci. 368, 629–635 (2012). 
148. Wang, G., Akiyama, Y., Takarada, T. & Maeda, M. Rapid Non-Crosslinking Aggregation of 
DNA-Functionalized Gold Nanorods and Nanotriangles for Colorimetric Single-Nucleotide 
Discrimination. Chem. - A Eur. J. 22, 258–263 (2016). 
149. Lee, J.-S., Han, M. S. & Mirkin, C. A. Colorimetric Detection of Mercuric Ion (Hg2+) in 




150. Retout, M. et al. Rapid and Selective Detection of Proteins by Dual Trapping Using Gold 
Nanoparticles Functionalized with Peptide Aptamers. ACS Sensors 1, 929–933 (2016). 
151. Chang, C. C., Wang, G., Takarada, T. & Maeda, M. Target-recycling-Amplified colorimetric 
detection of pollen allergen using non-cross-linking aggregation of dna-modified gold 
nanoparticles. ACS Sensors 4, 363–369 (2019). 
152. McVey, C., Huang, F., Elliott, C. & Cao, C. Endonuclease controlled aggregation of gold 
nanoparticles for the ultrasensitive detection of pathogenic bacterial DNA. Biosens. 
Bioelectron. 92, 502–508 (2017). 
153. Chiu, T.-C. & Huang, C.-C. Aptamer-Functionalized Nano-Biosensors. Sensors 9, 10356–
10388 (2009). 
154. De La Rica, R. & Stevens, M. M. Plasmonic ELISA for the ultrasensitive detection of 
disease biomarkers with the naked eye. Nat. Nanotechnol. 7, 821–824 (2012). 
155. Zhou, Y. & Ma, Z. Colorimetric detection of Hg2+by Au nanoparticles formed by 
H2O2reduction of HAuCl4using Au nanoclusters as the catalyst. Sensors Actuators, B 
Chem. 241, 1063–1068 (2017). 
156. Plasmonic colorimetric sensors based on etching and growth of noble metal 
nanoparticles: Strategies and applications - ScienceDirect. Available at: https://www-
sciencedirect-com.biblio.iit.it/science/article/pii/S0956566318303567. (Accessed: 7th 
February 2021) 
157. Rao, H., Xue, X., Wang, H. & Xue, Z. Gold nanorod etching-based multicolorimetric 
sensors: Strategies and applications. Journal of Materials Chemistry C 7, 4610–4621 
(2019). 
158. Ma, X. et al. A universal multicolor immunosensor for semiquantitative visual detection of 
biomarkers with the naked eyes. Biosens. Bioelectron. 87, 122–128 (2017). 
159. Zhang, Z., Chen, Z. & Chen, L. Ultrasensitive Visual Sensing of Molybdate Based on 
Enzymatic-like Etching of Gold Nanorods. Langmuir 31, 9253–9259 (2015). 
160. Weng, G., Dong, X., Li, J. & Zhao, J. Halide ions can trigger the oxidative etching of gold 
nanorods with the iodide ions being the most efficient. J. Mater. Sci. 51, 7678–7690 
(2016). 
161. Jiang, C. et al. Chitosan-gold nanoparticles as peroxidase mimic and their application in 
glucose detection in serum. RSC Adv. 7, 44463–44469 (2017). 
162. Han, K. N., Choi, J. S. & Kwon, J. Gold nanozyme-based paper chip for colorimetric 
detection of mercury ions. Sci. Rep. 7, 1–7 (2017). 
163. Wu, Y. et al. Accelerating peroxidase-like activity of gold nanozymes using purine 
derivatives and its application for monitoring of occult blood in urine. Sensors Actuators, 
B Chem. 270, 443–451 (2018). 
164. Shah, J., Purohit, R., Singh, R., Karakoti, A. S. & Singh, S. ATP-enhanced peroxidase-like 







2 Gold nanoparticles noncatalytic/ 
nanoplasmonic based sensor for organic 
mercury detection 
 
2.1 Introduction to colorimetric mercury 
species detection methods 
 
Nowadays, the detection and quantification of mercury species (Hg2+, MeHg+) are 
done by using Inductively Coupled Plasma spectrometry (ICP-MS)1–3, Atomic 
Fluorescence Spectrometry, Cold Vapor Atomic Absorption spectroscopy (CVAAS), 
Cold Vapor Atomic Fluorescence spectroscopy (CVAFS)4,5, High Performance 
Liquid Chromatography (HPLC) and Gas Chromatography (GC). However, these 
techniques, even if highly sensitive, are expensive, as they require complex and 
costly instrumentation, laborious protocols and qualified personnel. Therefore, 
there is a strong need of portable and easy-to-use devices for the simple and rapid 
home testing of these threating pollutants. Harvesting the potential recently 
opened by the application of nanoparticles to analytic issues, several colorimetric 
nanosensors have been recently proposed for naked-eye detection of mercury6,7. 
However, the sensitivity and reliability are still a major challenge for routine 
monitoring application. Moreover, only few reports deal with the detection of 
organic mercury8, which is the most abundant and dangerous species in fish flesh. 
In the field of nanosensors for diagnostic and environmental control, AuNPs have 
been exploited to develop different detection strategies 9. In particular, there are 
several reports regarding mercury species detection via optical read out 
approaches 10–12. Many of them are based on the AuNPs color shift (related to the 
nanoparticles surface plasmon resonance), caused by the analyte-induced 
aggregation. Other studies are focused on the catalytic properties of nanoparticles 
that are affected by the presence of mercury and can be then further 
quantitatively transduced in a signal employing chromogenic or fluorescent 
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substrates13,14. To improve as possible the efficiency and the selectivity of analyte 
recognition step, those nanomaterials are usually functionalized with ssDNA, 
surfactants, thiols and other ligands15. While for inorganic mercury some 
colorimetric detection strategies have been recently reported due to the possible 
exploitation of Hg2+ reactivity and direct interaction with noble metal NPs, such as 
gold and platinum16, detection of methylmercury was hampered to date in POC 
schemes because of its challenging reduction to its metallic form via simple and 
biocompatible reagents and methods. This prevented the implementation of 
portable colorimetric methods, since organic forms cannot directly interact with 
nanoparticles or chromogenic substrates. In a recent study15, a colorimetric 
strategy for organic Hg has been achieved using a combination of AuNPs, copper 
ions, diethyldithiocarbamate (DDTC), and EDTA in a multi-step reaction, exploiting 
the Hg/Cu displacement in DDTC complex, with its consequent surface interaction 
and destabilization of the AuNPs. Moreover, in a different work17, a strong 
reducing agent 4-(2-Hydroxyethyl)piperazine-1-(2-hydroxypropanesulfonic acid) 
monohydrate (HEPPSO) has been employed in an interesting and sensitive 
strategy to convert organic mercury to Hg0, which inhibits the dual chromogenic 
functionality of HEPPSO. This latter approach, however, showed some limitations 
as a POC sensor, in terms of long operational procedure and use of strong 
reagents. Other approaches, which rely on the use of thymine-rich aptamers 
coupled to AgNPs, , need for controlled temperature cycles, or instrumental 
fluorescence detection12,18, together with long reaction times. Similarly, thymine-
functionalized AuNPs have been exploited in a Hg-induced cross-linking 
configuration, although reaching low sensitivity8. The characteristics of the main 
methods have been summarized in Table 2.1. Here, we demonstrate how citrate-
capped gold Au NPs can be effectively used to detect both inorganic and organic 
mercury species exploiting simultaneously their catalytic and plasmonic 
properties. This method consists in an aggregation reaction induced by the 
formation of Hg0 amalgam on particles surface as a consequence of mercury 
species reduction catalyzed by the AuNPs. Without adding any functional groups 
on the surface of the nanomaterial, we can reach remarkable limit of detection 
46 
 
(LOD) equal to 2 µM, while color change associated with the aggregation process 
is complete in less than 2 minutes. 
 
 
2.2 Materials and methods 
 
All chemicals and reagents employed were of high technical grade, stored 
following vendor recommendations and directly used with no further purification. 
Hydroxylamine sulfate (H3NO•0.5H2SO4, 88944) and Hydrogen Tetrachloroaurate 
(HAuCl4*XH2O, Au 49% min, 42803) were purchased from Alfa Aesar. Sodium 
citrate tribasic hydrate (HOC(COONa)(CH2COONa)2, Reagent Plus®, ≥99%, 25114 










Chi-Wei Liu et al.19 ✕ ✓ ✕ ✕ 
Huang Chih-Ching 20 ✕ ✕ ✕ ✓ 
Chen Guan-Hua  21  ✕ ✓ ✓ ✕ 
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This work ✓ ✓ ✓ ✓ 
 
Table 2.1 Analysis of the characteristics of the main methods for organic mercury detection, 
together with selected methods detecting inorganic mercury. 
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2.2.1 Synthesis of AuNPs 
 
Colloidal 15 nm citrate-capped AuNPs were synthesized by the classical Turkevich–
Frens method25 using sodium citrate as the reducing agent. All glassware was 
washed with aqua regia (HCl and HNO3, in a 3:1 volumetric ratio). 75 mL of 0.25 
mM acqueous solution of HAuCl4 was added in a two-neck round-bottom flask, 
connected to a bulb condenser and. After reaching boiling point (using silicon oil 
as heating fluid, setting the temperature at 110°C), 1.4 mL of 1% aqueous solution 
of trisodium citrate were added. The solution was kept gently boiling for 25 min.  
In a second step, 35 nm citrate capped AuNPs were synthetized according to a 
previously published method26. Briefly, the procedure relies on a seed-mediated 
growth using the 15 nm AuNPs (seeds) and NH2OH, which efficiently reduces Au3+ 
in presence of Au surface. To determine the volume of seeds required, a 
preliminary calibrating synthesis is performed for the desired final particle size. 1 
mL of 15 nm Au seeds solution were diluted in a round-bottom flask, under 
vigorous stirring and at room temperature, into 60 mL of MilliQ water, followed 
by the adding of 200 µL of 100 mM hydroxylamine sulfate solution. Then, 5 mL of 
HAuCl4 2 mM were added at 90 ml/h by syringe pump. After the addition of 
HAuCl4, 1.3 mL of 100 mM trisodium citrate were added, to stabilize gold 
nanoparticles. Unreacted reagents were removed by centrifugation in 50 mL 
polycarbonate tube at 3800 rcf, for 25 minutes. Concentrated AuNPs batch was 
collected and stored at 4°C, until the use. 
 
2.2.2 UV-vis characterization   
 
In a 1.5 mL tube, 10 µL of a solution containing various concentrations (2.5-20 nM) 
of 35 nm AuNPs were added to 990 µL of an aqueous sample spiked with CH3Hg+. 
The mixture was then shacked and incubated with 3% v/v formic acid (50-1000 
mM). Typically, the reaction started in 30 seconds and the color change was 
complete in a minute. UV-vis spectra (400-800 nm) were acquired by a NanoDrop® 
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(Thermo Fisher) with a small volume cuvette or by Spark® multimode microplate 
reader (Tecan) with flat transparent 96 multiwell plate. 
2.2.3 TEM imaging 
 
The TEM images of AuNPs deposited on carbon coated grids were acquired by a 
JEOL JEM 1400 microscope.  
 
2.2.4 X-ray Photoelectron Spectroscopy (XPS) 
analyses 
The XPS analyses were carried out with a Kratos Axis Ultra spectrometer, using a 
monochromatic Al Kα source, operated at 20 mA and 15 kV. The sample for XPS 
characterization was prepared by drop casting a few microliters of a 100-fold 
concentrated solution of a spiked sample containing MeHg+ (100M), AuNPs 
(20nM), and formic acid (150 mM) on a freshly cleaved highly oriented pyrolytic 
graphite (HOPG) substrate (NT-MDT, ZYB). Wide scan analyses were carried out 
with an analysis area of 300 x 700 microns and a pass energy of 160 eV. High 
resolution analyses were carried out with the same analysis area at a pass energy 
of 10 eV. Spectra were analysed using Casa XPS software (version 2.3.17). 
 
2.2.5 NMR characterization 
 
All the NMR experiments were performed at 298 K on a Bruker Ultrashield Plus FT-
NMR 600 MHz ADVANCE III equipped with a CryoprobeTM QCI 1H/19F–13C/15N–
D and with a SampleJetTM autosampler with temperature control. For each 
sample, a 1D 1H NMR spectrum was recorded; the water suppression was 
obtained using a standard pulse sequence (NOESY presat; Bruker) with 64 k data 
points, a spectral width of 20 ppm, an acquisition time of 2.7 s, a relaxation delay 






2.3.1 Sensing strategy 
 
The oxidation or reduction of heavy metal inorganic and organic compounds has 
been seldomly used for the development of nanosensors since the kinetics of 
these reactions can be extremely slow without the addition of a strong reducing 
or oxidizing agent that adversely interferes with the determination of the 
substance. This has been overcome in the paper published by my mentor’s 
laboratory by using the catalytic surface properties of AuNPs, able to effectively 
harness the weak reducing ability of formic acid to obtain the reduction of 
methylmercury to elemental mercury on the nanomaterial interface.  The reaction 
between formic acid and methylmercury is catalysed at the surface of the gold 
nanomaterial and leads to the reduction of methylmercury and to the formation 
of a layer of metallic mercury on the surface of Au NPs. This results in a 
modification of the AuNPs colloidal dispersion and, as a consequence, in a change 
of the AuNPs plasmonic properties. Indeed, the mixture loses the red colour of a 
stable colloidal AuNPs solution and becomes blue/violet as AuNPs get closer to 
each other and aggregate with the consequent modification of their plasmonic 
properties detected by naked eye (Figure 2.1). This mechanism based on the 
catalytic and plasmonic properties of AuNPs permits to drastically improve the 





Figure 2.1 Detection mechanism triggered by the Red-Ox reaction at the surface of AuNPs between 
formic acid and methylmercury. As soon as reduced elemental mercury (Hg0) nucleates on AuNPs 
surface, fast particle aggregation is observed, with clear red-to-violet color change of the solution. 
 
2.3.2 AuNPs characterization 
 
The first step was the AuNPs synthesis: as previously described (paragraph 2.2.1), 
citrate-capped 15 nm AuNPs have been produced and then used as seeds in a 
further growing reaction to obtain 35 nm AuNPs. Both 15 and 35 nm nanoparticles 
have been characterized in size and shape. The results are shown below (see 
Figure 2.2 and Figure 2.3).  The method allowed to obtain well monodispersed, 
spherical AuNPs.  The UV-vis spectra reports a maximum of absorbance at  = 520 
nm peculiar of 15 nm spherical nanoparticles, according to AuNPs plasmonic 
theory (see Figure 2.2 (A)) and the DLS analysis report a narrow peak (Z-Ave = 15.2 
nm) without side population of aggregates (see Figure 2.2 (B)). In the Figure 2.2 
(C) the size distribution calculated on statistical significative population of particles 





Figure 2.2 15 nm AuNPs characterization (A) UV-vis absorption spectrum in water, (B) DLS 
measurement (C) TEM size distribution analysis showing a monodisperse population with an 
average size of 15 nm, (D) representative TEM micrograph. 
 
The same characterization in terms of size distribution and stability has been 
performed for 35 nm citrate capped AuNPs. The Figure 2.3 (A) shows the UV-vis 
absorption spectra with  max = 525 nm according to plasmonic theory. The DLs 
analysis confirm the particles size with one peak at Z-Ave = 36 nm (see Figure 2.3 
(B)). In Figure 2.3 (C) has been reported the distribution of the diameters 
measured on statistical significative sample of particles after TME images 







Figure 2.3 35 nm AuNPs characterization (A) UV-vis absorption spectrum in water, (B) DLS 
measurement (C) TEM size distribution analysis showing a monodisperse population with an 
average size of 35 nm, (D) representative TEM micrograph. 
 
2.3.3 NMR characterization 
 
The proposed sensing scheme and its underlying reactions were characterized by 
nuclear magnetic resonance (NMR), transmission electron microscopy (TEM), X-
ray photoelectron spectroscopy (XPS), and absorption spectroscopy (UV-vis). First, 
to confirm the role of the AuNP as catalyst for the MeHg+ reduction, 1H NMR 
spectra have been acquired during the reaction. A sharp signal around 0.9 ppm 
represents the aqueous solution containing methylmercury (Figure 2.4 a)27,28. As 
expected, the addition of formic acid did not elicit any detectable change in the 
spectrum, as such weak reductants are not able to reduce methylmercury (Figure 
2.4 b)27,29,30. Even after several days of incubation, we did not observe any 





not cause any significant effect (see Figure 2.4 c). Noteworthy, in presence of both 
AuNPs and formic acid, a significant decrease in the signal of methylmercury was 
visible already after few minutes, indicative of the strong activity of the 
nanocatalyst (see Figure 2.4 d). In the same spectrum, the 1H NMR signal of the 
methane produced during the reaction is also visible, while no methane signals 




Figure 2.4 Expansion regions between 1 and 0 ppm of the 1D 1H spectra recorded for (a) 
methylmercury (MeHg+) in water; (b) in presence of formic acid; (c) in presence of AuNPs; (d) in 
presence of both AuNPs and formic acid. 1 and 2 indicate the NMR signals of some impurities 
present in all the samples. Red asterisks indicate the absence of methane signals 
 
Therefore, the gold nanocatalyst is crucial for the reaction to happen, allowing fast 
organic mercury conversion to its metallic form. To further investigate the AuNPs 
catalytic activity, increasing concentrations of NPs have been tested (see Figure 
2.5). Going from a concentration of AuNPs of 78 pM to one of 468 pM, the NMR 





Figure 2.5 Expansion regions between 1 and 0 ppm of the 1D 1H spectra recorded for 50 M CH3Hg+ 
in MilliQ 50% D2O, 200 M citric acid and 50 mM formic acid (bottom line) and after the addition 
of increasing concentrations of AuNPs (78-468 pM). The 1H NMR signal of MeHg+ clearly decreases, 
as a function of increasing Au-NP concentration. At the highest particle concentration, the reaction 
is complete (*). 
 
2.3.4 XPS characterization 
 
To verify the presence of metallic mercury on the surface of AuNPs, XPS 
measurements were performed on the particles after incubation with 
methylmercury. Figure 2.6 shows the XPS data collected over the binding energy 
typical for Au 4f and Hg 4f peaks. Each Au 4f (Hg 4f) level is represented by a 
doublet, due to spin‐orbit coupling, showing an intensity ratio of 4:3 between the 
7/2 and 5/2 components and a doublet splitting of 3.67 eV (4.05 eV)31. The 
oxidation state of both Au and Hg could be estimated by evaluating the position 
of their 4f7/2 components. Au 4f7/2 and Hg 4f7/2 were found at a binding energy 
of (83.9±0.2)eV and (99.6±0.2)eV, respectively, indicating that both Au and Hg are 
present in their metallic state in the sample31. By calculating the Hg and Au peak 
areas and after normalization to the corresponding relative sensitivity factors 
(parameters that can be related to the cross section of the X‐ray induced 
photoemission process), the Au:Hg atomic ratio was calculated to be 90.4:9.6. ± 
0.5. These data indicate the presence of metallic mercury on the AuNP surface, in 






Figure 2.6 High resolution XPS spectrum showing the Au 4f and Hg 4f peaks. The position of the 
XPS peaks indicates that both Au and Hg are present in the sample in their metallic state. 
  
 
2.3.5 TEM characterization 
 
TEM images were then acquired on the AuNPs before and after the detection 
reaction with methylmercury. Unlike the pristine status of AuNPs in the initial state 
characterized by separated particles on the grid (see Figure 2.7 A,B), the formation 
of mercury amalgam is clearly evident after methylmercury incubation, with the 
presence of large particle aggregates fused together (see Figure 2.7 C,D). This 
envisages possible color change of the AuNP solution, due to aggregation-induced 
plasmon shift. TEM images clearly show the aggregation process: while before the 
assay the AuNPs are well monodispersed, after the catalyzed organic mercury 
reduction, the nanoparticles appear densely aggregated as a result of mercury 





Figure 2.7 Representative TEM images of AuNPs before (A,B) and after (C,D) the incubation with a 
spiked sample containing methylmercury. 
 
2.3.6 UV-vis characterization   
  
The spectral response of our colorimetric test was characterized by UV-vis 
spectroscopy (see Figure 2.8). A fast and constant decrease of the plasmon band 
around 520 nm, ascribed to monodispersed AuNPs, and a related increase of a 
broad absorbance of aggregate population (650-780 nm) were clearly observed, 
in line with TEM data. Interestingly, the process was complete in less than 2 











Figure 2.8 Time-dependent absorption spectra of AuNPs (200 pM) upon incubation with 
methylmercury (0.2 ppm) in presence of formic acid. A very fast aggregation process can be 
observed in 1 minute, with a clear colour change of the solution, in the inset graph the aggregation 
rate as Abs750/Abs520. 
 
Noteworthy, the colorimetric test can be also assessed by simple visual inspection. 
As reported in Figure 2.9 A, the red-to-violet color change elicited by the presence 
of methylmercury could be clearly observed after only 1 minute of incubation, 
even in the case of low levels of contamination. After systematic optimization, the 
Limit-Of-Detection (LOD) of our assay by naked-eye was found to be around 0.1 
ppm. This is important in view of real applications to food contaminations (e.g. on 
fish samples), where the exposure limit is 0.5-1.0 ppm mercury (depending on the 
food species). Moreover, since real samples from water to food extracts might 
contain various metallic cations that can interfere with the detection of CH3Hg+ 
giving false positive signals, the selectivity of proposed method was assessed 
against different ions, tested at high concentration (i.e. 1 ppm, that is 10-fold our 
LOD). As shown in Figure 2.9 A, only mercury contamination elicited a significant 
increase of 750nm/620nm absorbance ratio, which corresponds to a clear color 
change, while the other analyzed cations did not produce any significant spectral 
change. The test selectivity is due to the specific affinity of reduced mercury with 




Figure 2.9 (A) Selectivity of presented method versus other toxic metallic cations, in terms of 
absorbance ratio measured at the end point of aggregation kinetic (after 180 sec). The results are 
expressed as mean ± SD of triplicate experiments. (B) efficiency and selectivity of the nanosensor 
in presence of high concentrations of interfering cations (Fe3+), using PVP-AuNPs. Absorption 
spectra of 35 pM AuNPs before (red line) and after (dashed red line) incubation with 100-fold 
excess of Fe3+ (12,5 ppm), and subsequent incubation (blue line) with methylmercury (125 ppb).  
Representative photograph of the naked-eye colorimetric response (inset). 
 
2.3.7 Real samples testing  
 
As a consequence of samples complexity (e.g. high concentration of solutes and 
ionic strength) AuNPs requires further stabilization to avoid unspecific 
aggregation. Several polymers are tested as stabilizing agent. Specifically, a 
picomolar solution of AuNPs has been incubated overnight under stirring with 
different concentrations of Polyvinylpyrrolidone (PVP), Polyacrylic acid (PAA) and 
Polyethylene glycol (PEG). After being washed, the particles stability is evaluated 
monitoring the plasmon shifting over the time in presence of different 
concentrations of sodium chloride (NaCl) (see Figure 2.10). PVP-stabilized AuNPs 
showed remarkable performance in real biological samples, like urine, where this 
sensor can detect low concentration of methylmercury, spiked in the sample. The 
nanosensor performance properly maintained its efficiency and selectivity even in 





Figure 2.10 (A-D) Absorption spectra of PAA-coated AuNPs, (E-H) Absorption spectra of PEG-
coated AuNPs, (I-N) Absorption spectra of PVP-coated AuNPs. PVP 10K results to be the best 
stabilizing agent on mercury sensing conditions. 
 
 
Figure 2.11 (A) Absorption spectra of the colorimetric nanosensor using PVP-coated AuNPs. The 
spectral analysis was performed with 30 pM AuNPs before (red line) and after (blue line) 1-minute 
incubation with methylmercury (25 ppb) and formic acid. (B) PVP-AuNPs based nanosensor in 







2.4 Conclusions  
 
Here, we exploit the interesting property of AuNPs to efficiently catalyze the fast 
transformation of methylmercury in the Hg0 form, even in presence of a weak and 
biocompatible reducer, such as formic acid. The potential of nanocatalysts to 
promote reduction of organic mercury in absence of strong reducers has been 
previously reported in photocatalysis with titania NPs, and in case of 
electrocatalysis with AuNP-functionalized electrode. In our strategy, such process 
allows quasi-simultaneous metallic mercury nucleation on the AuNP surface and 
amalgam formation, with prompt particle destabilization and aggregation. Thus, 
the coupled catalytic/plasmonic functionality of AuNPs allows for ultrafast and 
specific naked-eye detection of organic mercury at relevant concentrations, due 
to metal-induced shift of the plasmonic band. These results open interesting 
perspectives for the development of low-cost, rapid, and portable sensors, 
enabling frequent screening of organic mercury contaminations, which represents 
an important option for routine food assessment, as well as for health and 
environmental protection. Interestingly, the overall reaction that leads to the fast 
and sensitive detection of organic mercury can be performed at ambient 
conditions, with stable and “green” reagents, thus opening promising perspectives 
toward frequent mercury screening by point-of-care devices. In particular, the 
possibility to use biocompatible and weak reducing agents, such as formic acid, is 
enabled by the action of the surface of gold nanocatalyst, as clearly proven by the 
NMR analysis. Indeed, in such sensing scheme, the use of stronger reductants (e.g. 
sodium borohydride) is hampered by immediate AuNP destabilization and loss of 
assay sensitivity and specificity. This makes the interplay of the 
nanocatalyst/nanoplasmonic activities and reactants strength unique. Considering 
that this detection protocol can be easily monitored by naked-eye, and that it has 
high selectivity and short reaction time, the method has been patented (n° 
102018000008034 date: 10/08/2018). The presented results are published as 
Nanocatalyst/Nanoplasmon‐Enabled Detection of Organic Mercury: A One‐
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3 Nanoplasmonic gold nanoparticles-based 
sensor for salivary glucose assessment  
 
3.1 Gold nanoparticles for glucose detection  
 
Gold nanoparticles have been largely used in colorimetric sensing of variety of 
analytes, from DNA sequences to metal ions1–4. One of the most popular strategies 
is based on the controlled aggregation, in which a decreased distance between 
nearby particles results in a plasmon coupling effect and related band shift and 
consequent colour change5,6. Even if this approach exhibits great sensibility, it 
presents auto-aggregation problems due to the bio-chemical samples 
composition, that may lead to false results since high concentration of proteins, 
salts and others solutes, strongly affect the AuNPs stability. Moreover, the 
required engineering of nanoparticles with recognition probes can be expensive 
and time-consuming. Recently, a group of “non-aggregation” methods is drawing 
the attention of the scientific community. These strategies based on the 
nanoparticle etching and growth result in a plasmon band shifting as a 
consequence of the particles re-modelling, achieving a sensible detection of 
biomarkers, virus, ions7. Nevertheless, also the growth approach presents some 
limitations when used in complex media such as biological fluids, in which the 
solutes like proteins, small molecules or salts can inhibit the reaction on the 
particle surface8,9. An effective “non-aggregation” approach is based on the 
etching of metal nanoparticles. This strategy has been used to detect metal ions, 
anions, glucose and amino acids. We can mention several mechanisms, depending 
on the agent that triggers the particles’ erosion: direct etching by targets, 
intermediate-mediated etching, alloy-promoted etching, enzyme-mediated 
etching. In the case of enzyme mediated etching, there are several published 
methods in which the hydrogen peroxide produced by the enzyme induces the 
oxidation of gold nanorods (AuNRs), resulting in a strong plasmon shifting7,10,11. 
However, the erosion step needs to be catalysed, and to obtain a clear colour 
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change, the AuNRs must be largely etched. These methods require strong 
conditions, long reaction times and lead to an obvious loss of optical density as a 
consequence of nanoparticles final reduced dimensions.  A colorimetric assay for 
blood glucose determination using this mechanism was explored on gold nanorods 
and the colour change was obtained following the particle corrosion and 
shortening in presence of glucose12. In a similar work, the glucose oxidase (GOx) 
enzyme reacts specifically with glucose in complex media producing H2O2 that, via 
Fenton or Fenton-like reactions, transforms in the free radical form able to rapidly 
oxidize (and partially dissolve) the AuNPs13,14.  
Likewise, a gold nano-bipyramid has been used as probe to dose glucose, 
exploiting the interaction of hydrogen peroxide and halogen that results in 
particles shortening11. Yet, also this work shows the same limitations previously 
reported. Despite of the number of available methods, there is still a lack of 
suitable tools for a fast and sensitive visual detection of biomarker, like glucose, in 
real biological samples.  
 
3.2 Materials and methods 
 
3.2.1 Chemicals and materials 
 
All chemicals and reagents employed were of high technical grade, stored 
following vendor recommendations and directly used with no further purification. 
Hydroxylamine sulfate (H3NO•0.5H2SO4, 88944) and Hydrogen Tetrachloroaurate 
(HAuCl4*XH2O, Au 49% min, 42803) were purchased from Alfa Aesar. Sodium 
citrate tribasic hydrate (HOC(COONa)(CH2COONa)2, ReagentPlus®, ≥99%, 25114), 
HEPES (BioUltra, for molecular biology, ≥99.5%, 54457), Potassium bromide 
(KBr,EMSURE® ACS,Reag. 1.04905), Potassium chloride (KCl, EMSURE®,1.04936), 
Potassium iodide (KI, for analysis EMSURE® ISO,Reag, 1.05043 ), D-(+)-Glucose 
(C6H12O6 ACS reagen, G5767) and Glucose Oxidase from Aspergillus (Type X-S, 
lyophilized powder, G7141) were purchased from Sigma-Aldrich. Nylon membrane 
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filters (Whatman® pore size 0.45 μm, 13 mm Ǿ, thickness150-187 µm, 
WHA7404001), Nitrocellulose membrane filters (Whatman®  pore size 0.45 μm, 
13 mm Ǿ, WHA7184001), PDVF Membrane filters (Millipore Durapore®, pore size 
0.45 µm, hydrophilic, 13 mm Ǿ, HVLP01300) were purchased from Sigma-Aldrich. 
Syringe filter holder (re-usable polycarbonate, for 13 mm Ǿ filters, 0.5 cm2 
filtration area, 16514) were purchased from Sartorius. A high sensitivity glucose 
assay kit (Merck - MAK181-1KT) was employed as reference standard technique. 
If not specified differently, all solutions and buffers were prepared using ultrapure 
deionized water (MilliQ). The saliva samples were spontaneously donated from 
healthy subjects and their use in this study was approved by Ethical Committee. 
Saliva samples from diabetic patients were provided by the San Matteo hospital 
of Pavia. 
 
3.2.2 Synthesis of AuMBNPs  
 
60 nm multibranched gold nanoparticles (AuMBNPs) were prepared by slightly 
modified Maiorano–Pompa method19, optimized for our purposes. The procedure 
relied on a seed-mediated growth. Briefly, 6.5 mL of the prepared 15 nm gold 
seeds (1.8 nM), 0.28 mL of hydrogen tetrachloroaurate (100 mM) and 0.8 mL of 
hydroxylamine sulphate (100 mM) were consecutively added to 250 mL of HEPES 
solution (50 mM, pH = 7.0), under vigorous stirring. After 15-20 minutes at room 
temperature, the reaction mixture becomes blue. Residual reagents excess was 
removed by centrifugation (400 RCF, 25 min). AuMBNPs were characterized by 
DLS, UV-vis spectrophotometry and TEM.  
 
3.2.3 UV-visible spectroscopy 
 
UV-vis spectra (400-800 nm) of the nanoparticle suspension were acquired by a 
Thermo Fisher NanoDrop® (wavelength Accuracy ± 1 nm, absorbance accuracy 3 
% at 0.74 Abs@350nm) with a small volume cuvette or by Tecan Spark® multimode 
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microplate reader (wavelength accuracy < 0.3 nm, absorbance accuracy < 
0.5%@260) nm with flat transparent 96 multiwell plate.   
 
3.2.4 Reflectance spectroscopy 
 
Reflectance spectra were recorded on dried substrates using Ocean Optics 
spectrophotometer equipped with a reflection probe and an OCEAN-HDX-XR 
detector. For the white balance, a reflectance standard was employed (Diffuse 
Reflectance Std, Spectralon). 
 
3.2.5 Optimization of pH conditions  
 
Different acetate buffers (14 mM) were prepared varying the ratio between acetic 
acid and sodium acetate to obtain three solutions with pH 4.5, 5.0 and 5.5, 
respectively. 20 µL of AuMBNPs (0.5 nM, ALSPR = 0.8, ɛ = 16.87 × 109 M-1cm-1), 
20 µL of KBr (50 mM) and 20 µL of H2O2 (2.5 mM) were added to 140 µL of the 
different acetate buffer solutions (pH = 4.5, 5.0 and 5.5). Controls were performed 
in absence of H2O2 (replaced by 20 µL of H2O). The experiment was performed in 
a 96-multiwell plate and absorption spectra were recorded at room temperature 
by Tecan plate reader to monitor the reaction over the time. 
 
3.2.6 Halogen screening 
 
Three halogen ion solutions were used at their “best” operational concentration 
(previously experimentally identified), since, due to their very different reactivity, 
employing them at the very same concentration would have not allowed for a fair 
comparison among their potential role in the sensing platform. KCl (500 mM), KBr 
(50 mM) and KI (50 µM) were the selected stock solutions used in this study. 20 µL 
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of AuMBNPs (0.5 nM, ALSPR = 8.0, ɛ = 16.87 × 109 M-1cm-1), 20 µL of acetate 
buffer (100 mM, pH = 5) and 20 µL of halogen stock solution were added to 140 
µL of H2O2 (2.86 mM). H2O2 final concentration was 2 mM in the total volume.  
 
3.2.7 Efficiency of hydrogen peroxide detection 
 
Several sample solutions with different H2O2 concentrations were prepared (0, 
0.71, 2.14, 3.57 and 4.29 mM). 20 µL of AuMBNPs (0.5 nM, ALSPR = 0.8, ɛ = 16,87 
×109 M-1cm-1), 20 µL of KBr (50 mM) and 20 µL of acetate buffer (100 mM, pH = 
5) were added to 140 µL of the prepared H2O2 solutions (presenting, in the total 
volume, a final concentration of 0, 0.5, 1.5, 2.5 and 3 mM). The experiment was 
performed in a 96-multiwell plate and absorption spectra were recorded at room 
temperature by Tecan plate reader to monitor the reaction over time.  
 
3.2.8 Optimization of the reshaping process in   
water 
 
20 µL of AuMBNPs (0.5 nM, ALSPR = 0.8, ɛ = 16,87 ×109 M-1cm-1), 20 µL of KBr (50 
mM) and 20 µL of acetate buffer (100 mM, pH = 5) were added to 140 µL of 
H2O2solution presenting, in the total volume, a final concentration of 3 mM.  
 
3.2.9 Saliva sampling  
 
The saliva samples were spontaneously donated from healthy subjects, and their 
use in this study was approved by Ethical Committee. Donors were asked to avoid 
eating, drinking and oral hygiene procedures for at least one hour before saliva 
collection. Furthermore, donors were asked to provide unstimulated saliva (no 
speaking or swallowing for one minute prior to collection). Samples were collected 
by the donor into a 15 mL sterile and protein lo-bind falcon tube. The tube was 
stored at 4 °C and processed within one hour from donation.  The sensing platform 
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was conceived for self-monitoring of untreated whole saliva, however in this work 
we employed saliva samples from different donors and therefore, for safety 
reasons, samples were manipulated under the chemical hood and filtered (0.2 µm 
methyl cellulose syringe filter) from bacteria. Saliva samples from diabetic patients 
were provided by the San Matteo hospital of Pavia. 
 
3.2.10 Salivary glucose assay in suspension 
 
Hyperglycemia conditions were simulated by supplementing the collected saliva 
samples (see the saliva sampling section) with a glucose solution in order to reach 
pathological concentrations (2 mM, 36 mg/dL). Non-supplemented saliva 
representing physiological normal condition was used as a control. 20 μL of 
AuMBNPs (0.5 nM), 20 μL of GOx (0.021 mg/mL, 3 U/mL) in acetate buffer (50 mM, 
pH = 5), and 80 μL of KBr solution (5 M) were added to 80 μL of glucose 
supplemented saliva under stirring at 37 °C.  
 
 
3.2.11 TEM analysis on AuMBNPs morphological 
changes  
 
The glucose assay was performed as described in the previous section. The mixture 
was stirred at 37 °C for 10 min and, after colour change from blue to red, the 
reaction was stopped diluting and washing (centrifugation and resuspension 
process) the nanoparticles with cold (4 °C) HEPES buffer (10 mM, pH = 8.0). The 
control experiment was performed using non-supplemented saliva. The obtained 







3.2.12 Glucose dipstick, substrate preparation 
 
0.4 mL of a freshly prepared AuMBNPs suspension (25 pM, ALSPR = 0.4) in HEPES 
buffer (25 mM, pH = 7.0) were passed through a 0.4 µm porous nylon membrane 
using a syringe filter holder. The system was maintained in a vertically position 
promoting the uniform injection of the liquid and therefore uniform 
immobilization of the AuMBNPs on the membrane. Subsequently, 2 mL of air were 
injected to remove any residual water from the system. The prepared substrate 
was dried under vacuum for 10 minutes and then 15 µL of GOx solution (1 mg/mL, 
145 U/mL) in acetate buffer (100 mM, pH = 5) were deposited by direct drop 
casting on the membrane.  
The coated nylon support was dried again under vacuum and, finally, stored in low 
humidity conditions.  
 
3.2.13 Glucose assay protocol 
 
The glucose tests were performed adding on the prepared substrate 50 µL glucose 
supplemented saliva (90 – 180 μM, 1.5 – 3 mg/dL) and 50 µL of KBr solution (5 M) 
in acetate buffer (10 mM, pH = 5). The tests were carried out incubating the 
supports at 37 °C for 15 minutes. The test can be also carried out at room 
temperature leading to the same outcome but requiring a slightly longer time 
window. 
 
3.2.14 Assay’s reliability and validation 
 
The glucose concentration of twenty saliva samples (eight from healthy subjects 
and twelve from diabetic subjects) was measured using a high sensitivity glucose 
assay kit (Merck - MAK181-1KT) chosen as a standard reference technique.  Six 
saliva samples from healthy subjects presenting a physiological glucose 
concentration < 2 mg/dL were selected to numerically estimate the colorimetric 
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changes of our device at a targeted threshold (4 mg/dL ± 0.5).  The glucose-
dependent assay’s color change was estimated after 15 min using Red, Green and 
Blue (RGB) coordinates acquired using ColorGrab (smartphone app). Glucose 
spikes were employed to normalize the saliva samples to 2.5, 4, and 6 mg/dL to 
evaluate the ∆RGB variability and the ∆RGB value range.  
 
 
3.2.15 Assay reproducibility and Limit-Of-Detection  
 
The experiments were performed using saliva samples from healthy donors, and 
the basal glucose concentration was measured using a high sensitivity glucose 
assay kit (Merck - MAK181-1KT) as a reference technique. The device 
reproducibility was tested using five independently produced assays, prepared 
with the same protocol. The reagents ratios were tuned to obtain an evident color 
change for salivary glucose concentrations ≥ 4 (± 0.5) mg/dL as the selected 
threshold. The reproducibility tests were performed using different glucose 
concentrations and identifying the color change numerically by extracting the RGB 
coordinates using Color Grab (smartphone free app).  
 
3.3 Results  
 
3.3.1 Sensing strategy 
 
Here we present an original customizable nano-biosensor that allows the fast and 
sensitive visual detection of salivary glucose. This nanosensor pushes forward the 
state of the art of “non-aggregation” strategies, solving issues like the reaction 
time and conditions or the reliability in biological systems, which has limited so far 
POCT applications. The platform involves both etching and growing processes 
resulting in a reshaping effect that leads to a fast plasmon shifting and avoids any 
optical density (OD) loss (see Figure 3.4).  The molecular mechanism underlying 
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the sensing strategy can be divided in two steps, one involving the oxidant species 
production and a second in which such species trigger a series of reactions, leading 
to AUMBNPs morphological changes. The enzyme produces hydrogen peroxide 
(H2O2) from the  quantitative oxidation of the biomarker, H2O2 react with the 
halogen ions (𝑋−), present in stoichiometric excess, producing  𝐵𝑟−,  𝐵𝑟2−,  𝐵𝑟3− 
and 𝐻𝐵𝑟𝑂 (the latter eventually converting to 𝐵𝑟2) that reduces the peroxide 
activation energy15. The second step consists of the etching of the nanoparticles. 
For this there are three possibilities16–18. In the first one, the halogen induces the 
H2O2 decomposition producing radicals (.OH) capable to oxidize gold. The second 
proposed strategy consists of  𝑋− acting as ligand, stabilizing the dissolved Au 
atoms and promoting the erosion. In the third and most probable mechanism, 
H2O2 forms 𝑋2 and 𝑋3
− that oxidize gold atoms (Figure 3.1).  
 
 








3.3.2 AuMBNPs synthesis  
 
15 nm citrate capped AuNPs have been obtained as previously described (see 
chapter2.) and used as seeds, 40 nm HEPES-capped AuMBNPs were synthetized 
as described in the paragraph 3.2, NPs size and shape have been characterized by 
UV-visible spectra, TEM and DLS analyses (see Figure 3.2). 
Furthermore, the AuMBNPs has been optimized in order to obtain several shapes 
in terms of tips number and length. To tune the nanostructure branching, both 
HEPES and hydroxylamine concentrations have been modulated. Obtained 
particles have been characterized in terms of plasmonic shift by UV-visible 
spectroscopy (Figure 3.3(C)) with a peculiar peak of the AuMBNPs. In Figure 3.3(B) 
has been reported the DLS analysis, performed to characterize particles dimension 
and aggregation state, the peak position at Z-Ave= 66 nm confirm the dimension 
and the absence of secondary populations. In Figure 3.3(A) has been graphed the 
distribution of the particles diameters measured on acquired TEM images (see 
Figure 3.3(D). 
Several AuMBNPs shapes have been synthetized and tested in terms of relative 
plasmon blue shifting (best sensitivity has been achieved for a 615< max< 650nm). 
The Figure 3.3(A) reports the spectra of three synthesis in presence of increasing 
concentration of HEPES, tuning the binding agent concentration the plasmon peak 
can be modulated changing the dimension of the AuMBNPs tips. In the same way 







Figure 3.2 AuMBNPs characterization, (A) frequency distribution, (B) DLS analysis and diameters, 
(C) UV-Vis spectrum and (D) TEM image of AuMBNPs. 
 
 
Figure 3.3 UV-Vis spectra of the 40 nm AuMBNPs grown in the presence of different concentrations 









3.3.3 Sensing strategy optimization 
 
The nanoplasmonic sensor is based on the reshaping process of the AuMBNPs. 
Differently from a classical etching process in which the corrosion causes 
nanosensor shape and size modification with related optical density (OD) loss (see 
Figure 3.4), in this case we exploit reshaping process. The oxidized Au3+ is reduced 
again in an Ostwald ripening-like process. Combining etching and growing the 




Figure 3.4 LSPR shifting resulting from the reshaping process in water; there is not any absorbance 
reduction since the particles dimension does not decrease over the process. 
 
As a first step, the nanosensors capability has been characterized in terms of 
sensibility as color change in aqueous environment to determine best operational 
conditions. Since the etching is favored in acidic media, the pH has been optimized 
in the same experiment, while the activity of three different halogen ions has been 
evaluated (𝐶𝑙−, 𝐵𝑟−, 𝐼−). After having optimized the reaction parameters, we 
have tested the platform sensitivity in a range of hydrogen peroxide 
concentrations in water as solvent. The optimal pH resulted to be pH=5, while the 
best selectivity was found using 𝐵𝑟− that promotes a clear LSPR blue shift in 
presence of hydrogen peroxide, while the control showed a relatively small color 




Figure 3.5 (A) LSPR λmax evolution over time related to AuMBNPs reaction with H2O2 and KBr at pH 
= 4.5 (green), pH = 5 (red) and pH 5.5 (blue), (B) LSPR λmax evolution over time related to AuMBNP 
reaction with H2O2 (3 mM) in presence of optimized concentrations of different halogens Cl- 
(green), Br-(red), I- (blue), (C) LSPR λmax evolution for different concentrations of H2O2 in water (3-
0 mM), (D) LSPR Δλmax evolution over time related to the reshaping in saliva and in water (the two 
model platforms performance at H2O2 final concentration of 2 mM). 
  
AuMBNPs plasmon shifting has been characterized in a dedicated experiment to 
evaluate the role of hydrogen peroxide in a long-term interaction that can lead to 
non-specific etched products. AuMBNPs have been incubate with hydrogen 
peroxide (0-30mM) and the UV-visible spectra have been recorded for two hours. 
Reshaping process takes place only in presence of suitable conditions while, higher 
concentration of hydrogen peroxide can erode nanoparticles causing size 
reduction and optical density loss (see Figure 3.6 A). Evolution of absorbances over 
the time, shows that tuning relative concentrations of halogen, peroxide and 






Figure 3.6 (A) Effect of hydrogen peroxide on AuMBNPs absorption intensity in water: absorption 
spectra related to AuMBNPs before (control) and after reaction with increasing concentrations of 
H2O2 (in presence of KBr). While H2O2 at 1-3 mM induced minimal absorption intensity variation, 
at higher concentrations (10-20-30 mM) significant loss of LSPR intensity was observed, suggesting 
that etching process occurred. (B) Evolution of optical density over the process suggests that 
etching/growing reactions interests AuMBNPs surface 
 
3.3.4 Reshaping process characterization  
 
To characterize and confirm the reshaping process, AuMBNPs dimensions have 
been measured. After having selected the shape indicators as tips number and 
length, together with the core diameter, several nanoparticles have been 
measured on acquired TEM images. The changes in morphology related to LSPR 
shifting are clearly visible in terms of number of tips and tips length. The 
morphological parameters measured to characterize the changes in shape are 
measured as reported in Figure 3.7C: d1 corresponding to the external diameter 
measured from tip to tip; d2, the core diameter, equal to the NP solid except the 
tips; d3 the tips length measured from the base to the end. While the (control) ctrl 
did not exhibit significant morphological changes, the saliva sample with 
pathological concentration of glucose led to nanostructures rearrangement from 
multibranched to spherical shape. (see Figure 3.7). The morphological analysis 
results are presented in Figure 3.8. The histograms show the comparison of 
dimensions with respect of the number of tips (N = 320), their length (N = 1700) 




Whitney test confirmed statistical significance (p-value < 0.001) of mean sizes 




Figure 3.7 TEM images of AuMBNPs after glucose assay in saliva (A)-(C) representative images of 
the AuMBNPs after testing non-supplemented saliva sample; (D)-(F) representative images of 




Figure 3.8 Statistical TEM analysis measuring tips (numbers and lengths) and “core” dimensional 
variation between control and sample nanostructures. Statistical significance was determined by 
Mann-Whitney test (***p < 0.001). 
(A) (B) (C) 




3.3.5 Saliva testing (in solution) 
 
Adapting this platform to real working conditions in saliva, employing glucose spikes, GOx 
enzyme, and a large excess of Br– (see scheme in Figure 3.1) resulted in a strikingly better 
performance than that in water. The system was so stable that we could employ much 
larger Br– concentration, without affecting the control. Proteins and metabolites present 
in saliva can rapidly coat the AuMBNPs forming the so-called biomolecular corona, which 
can act as an organic shield protecting and stabilizing the surface atoms. Stability of the 
AuMBNPs has been tested versus raw saliva with and without GOx enzyme. While most 
of colorimetric detection methods using nanoparticles can’t be exploited in real samples 
because of the complexity of  matrixes like saliva,  this nanosensor shows good stability 
maintaining particles surface properties (see Figure 3.9).  
 
Figure 3.9 (A) Characteristic LSPR red-shift related to the protein adsorption on plasmonic 
nanoparticles. (B) and (C) show no GOx effect on the LSPR. (D) Stability test of AuMBNPs in saliva: 
the absorption spectra show good colloidal stability over 60 min also in presence of the enzyme. 






Salivary proteins (i.e., mucin) promote higher colloidal stability limiting the surface 
availability by steric hindrance, while salivary thiols (i.e., cysteine, glutathione and 
others) can act as surface ligands. These factors together firmly preserve the 
AuMBNPs shape even in presence of a large excess of Br– that otherwise would 
lead to uncontrolled fast etching and immediate colour change even in absence of 
glucose. Indeed, the saliva medium allowed for a significant extension of the 
dynamic range of the assay along with a faster response, meaning that resolution 
and sensitivity were also strongly improved (see Figure 3.4 D). Analysing the  
physiological control (no added glucose), no significant spectral changes were 
observed, indicating a better resolution of the nanosensor in saliva compared to 
non-biological media (see Figures 3.4 D). This is a key point since it excludes the 
possibility of false positives, due to spontaneous color changes of the AuMBNPs in 
the test timeframe (10–20 min); furthermore, it guarantees a faster naked-eye 
recognizable color distinction, due exclusively to the glucose present in saliva. The 
presence of non-physiological glucose concentrations in saliva (≥2 mM), 
reproducing hyperglicemia conditions, indeed promote a spectral fast change with 







Figure 3.10 Reshaping process in saliva: AuMBNPs absorption spectra evolution over time during 
the assay using (A) glucose supplemented saliva (hyperglycemic condition) (B) physiological saliva 
(ctrl). For more details, see the experimental procedure section. 
 
 
3.3.6 Micro-Pad (-Pad) device fabrication  
 
In order to realize a portable home-testing device prototype, the sensing platform 
was transferred onto a solid substrate. Several casting methods have been tested 
to obtain a well monodispersed layer of AuMBNPs. Classical incubation-like and 
drop casting techniques resulted to be inadequate, leading to surface defects, for 
which reason, a filtering-based deposition method was chosen. To evaluate the 
particles retention capability, residual AuMBNPs (in washing water) have been 
dosed by UV-visible spectra of aqueous solution after deposition (see Figure 3.11 
B). Using a syringe filter holder, 600mL of AuMBNPs colloidal solution at O.D.= 0.9 
was homogenously deposited on 0.22 mm mesh size nylon membrane and then 
covered with a layer of glucose oxidase enzyme to produce the micro-Pad (-Pad) 
(see Figure 3.11 A). 
Among the different materials tested (including cellulose acetate, nitrocellulose, 
PVDF), a porous nylon membrane was selected, presenting well structured 






Figure 3.11 (A) Schematics of the AuMBNPs deposition on the membrane substrate. (B) UV-vis 
absorption spectra of a AuMBNPs (20 pM) aqueous solution before (black curve) and after filtration 
through different membranes (nitrocellulose, PVDF and nylon). All the AuMBNPs were retained in 
the nylon membrane, leading to colourless filtrate (no light absorption, blue curve). 
 
 
3.3.7 -Pad device characterization 
 
From the reflectance spectra, glucose supplemented saliva appeared to be ca. 50 
nm blue-shifted compared to the control (consistent with the data observed in 
suspension), with the curve minima corresponding to the particles LSPR. This is 
also a confirmation of the reshaping process occurring on the substrate, with 
spherical GNPs on the test membrane after exposure to hyperglycemic saliva (see 
Figure 3.12). The use of a solid substrate led to a significant improvement of the 
reagents stability. While colloidal dispersions of AuMBNPs in water lose their 
morphological and plasmonic properties overtime, the on-substrate assay showed 
excellent stability up to 6 months, meaning that also the enzyme functionality was 
maintained. An additional advantage is that, even after glucose testing, the “test 





Figure 3.12 (A) Reflectance spectra of the membrane substrates, related to control and sample 
(picture in inset), showing a clear blue-shift (from λ = 600–550 nm). (B) SEM image of control (scale 
bar 2m, inset scale bar 100nm), (C) SEM image of sample (scale bar 2m, inset scale bar 100nm). 
 
The -Pads surface was characterized by using reflectance spectroscopy and 
scanning electron microscopy (SEM).  From SEM imaging, we could observe the 
nanostructure morphology directly on the membrane. Comparing images of nylon 
and cellulose as solid substrate for -Pad fabrication is clearly visible how a more 
organized microstructure allows a monodisperse organization of deposed 
AuMBNPs. Nylon membrane can efficiently host and stabilize gold nanoparticles 
in a well monodisperse layer (see Figure 3.13 A, C, E) without compromising the 
reactivity. On the contrary, cellulose paper requires for higher concentration of 
AuMBNPs to obtain suitable colour intensity for naked eye applications since most 
of nanoparticles are trapped and covered on disordered fiber matrix (see Figure 












Figure 3.13 (A), (C) SEM images of Nylon membrane, (B), (D) SEM image of Cellulose membrane. 
(E) SEM image of Nylon membrane in back scattering mode with monodisperse AuMBNPs, (F) SEM 















3.3.8 Real saliva samples testing  
 
From an active collaboration with a group of Prof.ssa Mariangela Rondanelli, MD, 
PhD “Ospedale Policlinico San Matteo” of Pavia, we obtained a sets of saliva 
samples of diabetic subjects collected in normal and hyperglycemic conditions. 
Using a high-sensitivity glucose assay kit (Merck - MAK181-1KT) chosen as a 
standard reference technique, we initially defined the correlation between blood 
and salivary glucose. Since the literature is contradictory about glucose salivary 
levels and its correlation with blood levels, we tested two different collecting 
protocols in healthy and diabetic donors to characterize both the effect of salivary 
flow stimulation, and the lag time between blood and salivary glucose peaks over 
the day (also using traditional blood electrochemical glucometer). Considering the 
poor correlation and the high intra-subject variability that we observed, we had to 
improve the collecting protocol, preferring the fluid normally secreted 
(unstimulated) by all set of oral glands. In a comparative experiment, stimulated 
saliva samples show a lower correlation and higher variability (see Figure 3.14) 
compared with unstimulated samples collected at the same time (pairing blood 
glycemic conditions), 
 
Figure 3.14 (A) Salivary glucose level of stimulated samples (blue dots) and unstimulated ones 
(green dots).In the inset are illustrated mean values and standard deviation of each populations. 





Saliva samples were tested with the proposed micropad-like colorimetric assay 
prototype. A small amount (20 μL) of glucose supplemented saliva (with several 
glucose concentrations) was sufficient to trigger a rapid colour change from blue 
to red within 5–15 min, depending on the glucose concentration. Saliva samples 
from 4 different donors have been spiked using glucose standard solution adding 
1 mg/dL (Spl1), 2 mg/dL (Spl2) and 5 mg/dL (Spl3) using as control samples without 
GOx (Ctrl 1), with denaturized GOx (Ctrl 2) and without spikes (Ctrl 3). As reported 
in Figure 3.15, the µ-Pad allows the quantitative colorimetric glucose detection. 
By finely tuning the reshaping conditions is possible to achieve a threshold for ON-
OFF colour change suitable in fast screening applications. 
 
 
Figure 3.15 Preliminary validation of the glucose assay prototype on different saliva samples: 
picture of the glucose assay immediately after saliva sample addition on the membrane (left) and 
after 15 min (right). The saliva samples collected from different donors were tested with no 
additional glucose (Ctrl3) and supplemented with glucose (Spl1 = 1.5 mg/dL, Spl2 = 3 mg/dL, Spl3 
= 5 mg/dL) to reproduce hyperglycemic conditions. Additional controls in which the assay was 
performed on non-supplemented saliva but in absence of GOx (Ctrl1) or in presence of inactivated 
GOx (Ctrl2) were also included in the study. 
 
 
3.3.9 Colour change characterization 
 
The assay prototype was finally optimized for analysis on real samples, considering 
that physiological glucose concentration in saliva is commonly <2 mg/dL (<130 
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mg/dL in human serum) while it is ≥4 mg/dL for hyperglycemic condition (≥160–
200 mg/dL in human serum). It is important to stress that the correlation between 
hematic and salivary glucose is not based on a constant ratio over the whole range 
of concentrations. For this reason, aiming at an ON/OFF response as an alarm bell 
for healthcare, we set our threshold about ≥4 ± 0.5 mg/dL. For salivary glucose 
concentrations above this range values, the assay must produce an evident color 
change. To numerically estimate the colorimetric changes of our device and 
perform statistical data analysis, RGB and Ciano, Magenta, Yellow and Black 
(CMYK) coordinates of the substrate were acquired using a smartphone app. (see 
Figure 3.16) 
 
Figure 3.16 (A) (C) RGB and CMY coordinates evolutions in a “negative” sample for a glucose 
concentration < 4 ± 0.5 mg/dL, (B) and (D) RGB and CMY coordinates evolutions in a “positive” 








3.3.10 Limit-Of-Detection  
 
The ∆RGB (see formula below) obtained at different glucose concentrations was 
employed for statistical data analysis: 
∆𝑅𝐺𝐵 = √(𝑅𝑡1 − 𝑅𝑡0)
2 + (𝐺𝑡1 − 𝐺𝑡0)
2 + (𝐵𝑡1 − 𝐵𝑡0)
2 
 
Glucose spikes were employed to normalize the saliva samples to 2.5, 4, and 6 
mg/dL to evaluate the ∆RGB variability and the ∆RGB value range, allowing to 
identify our threshold. An evident colour change, expected for salivary glucose 
concentrations ≥ 4 (± 0.5) mg/dL after 15 min of test, was estimated to correspond 
approximately to ∆RGB ≥ 30 (± 10) while little or no color change is expected for 
physiological concentrations (∆RGB < 15 ± 5). Altogether, the twenty saliva 
samples were analysed for their basal content using our ON/OFF colorimetric 
assay and the commercial kit to perform a small clinical trial (see Figure 3.17). The 
acquired ∆RGB obtained at different glucose concentrations in after 15 minutes of 
test were also employed to calculate the LOD.  
 
 
Figure 3.17 (A) Analytical plot for LOD calculation, statistical significance was determined using a 
one-way ANOVA and Tukey’s multiple comparison test (****P < 0.0001). (B) ∆RGB data relative to 





The LOD was calculated based on the ratio between three times the standard 
deviation for the control and the angular coefficient obtained from the analytical 
curve (Figure 3.18(B)) (see formula below).      
 
𝑋𝐿𝑂𝐷 =  3,3 ∗ 𝑆𝐷𝑏𝑙𝑎𝑛𝑘/𝑏 
 
XLOD: limit of detection; SDblank: standard deviation of the naturally occurring 
pseudo-blank; b: slope of the calibration. The assay performances were very good 
and reproducible using different independently produced devices to analyse the 
same saliva sample from a donor, reaching a LOD of 0.4 mg/dL, in line with the 
best performing glucose colorimetric sensors reported20,21. However, some 
variability on the LOD values was expected when analysing saliva samples from 
multiple different donors (presenting some difference in the composition), 
resulting in a more representative average value of 1.4 mg/dL. Such LOD value is 
still appropriate for our ON/OFF detection, allowing to cope with the intrinsic 
biological variability or real clinical samples. 
 
 
Figure 3.18 Assay performance analysis: (A) Delta RGB for different spiked sample, in a ON-OFF 
setup samples containing glucose < 4 mg/dL report negligible colour change while 4 and 6 mg/dL 







3.4 Conclusions  
 
In conclusion, the nanoscale architecture of AuMBNPs and their sensitive 
plasmonic features were exploited for the development of a novel colorimetric 
assay for hyperglycemia, demonstrated to be effective in real saliva samples. 
Interestingly, the sensing platform, when operating in salivary medium, showed 
improved solidity and better dynamic range than in water, suggesting a proactive 
role of the biomolecular corona both in stabilizing the nanosensor and in 
promoting the reshaping process (instead of etching). The technological transfer 
from solution to the solid substrate finally led to the realization of a dipstick-like 
prototype for non-invasive self-monitoring of glycemia. The assay was finally 
validated as a rapid test (15 min) on various clinical samples showing good 
reliability and, with further technological development, great potential for future 
home-testing applications. Overall, it is important to stress that the designed 
sensing platform could be easily adapted for the monitoring of several other 
pathologies, directly involving different oxidase enzymes. 
Considering the high selectivity and sensitivity as well as the remarkable 
colorimetric readout, the nanosensor has been already patented as 
“Procedimento e kit per rilevare un analita in un campione”.P. Pompa and P. 
Donati 102020000007162 (2020). Moreover, in light of the results from real 
salivary samples glucose assessment, and the notable potentiality in a POCT device 
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4 Appendix: Platinum nanoparticles-based 
colorimetric sensor for mercury detection 
 
4.1 Platinum nanoparticles 
 
In recent years, platinum nanoparticles (PtNPs) have attracted impressive 
attention in many fields, such as chemical industry and renewable energies, for 
their selectivity and efficiency in catalysis1,2. PtNPs are effective heterogeneous 
catalysts, widely used in the hydrogenation, isomerization, and dehydrogenation 
reactions. Moreover, they are applied in the preparation of several high-value 
chemicals of food industry, such as vitamins and fats, as well as fine biofuel for the 
energy sector34–7.  
Another field of research involving the use of this nanomaterial concerns 
nanomedicine8. Thanks to their good cytocompatibility9,10 and the stability in 
biological environment11,12, PtNPs have been proposed, in combinations with 
other materials, as drug carriers in anticancer, radiothermal, and photothermal 
therapies9,10,13,14. Moreover, they represent good candidates for the second 
generation of high sensitivity nanobiosensors, due to their ability to act as artificial 
enzymes (nanozymes). Indeed, exploiting PtNPs in the signal amplification step, 
the colorimetric/fluorimetric response can be significantly enhanced15.  
 
4.1.1 Nanozymes  
 
The term “nanozyme” has been used for the first time by Manea et al. to define 
functionalized gold NPs with prominent ribonuclease-like activity16. Today, this 
definition is adopted for all the NPs exhibiting enzymatic-like activity17,18. Such 
artificial and often inorganic enzymes result to be highly stable, robust, and cost-
effective compared to the corresponding biological native form19. Moreover, they 
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offer a large surface-to-volume ratio and easy customizable surface for a variety 
of ligand conjugations.  
 
An important class of enzymes highly investigated in nanomedicine for biosensing 
and medical applications include20,21:   
• Peroxidase (HRP), an antioxidant enzyme that catalyses the oxidation of a 
substrate through the decomposition of peroxides, such as hydrogen peroxide 
(𝐻2𝑂2). 
2𝐴𝐻 + 𝐻2𝑂2   
𝑷𝒆𝒓𝒐𝒙𝒊𝒅𝒂𝒔𝒆
→        2𝐴 + 𝐻2𝑂    
• Oxidase, that promotes the oxidation of an antioxidant substrate with molecular 




→     𝐴 + 𝐻2𝑂            2 𝐴𝐻 + 𝑂2 +𝐻2𝑂  
𝑶𝒙𝒊𝒅𝒂𝒔𝒆
→     2𝐴 + 2𝐻2𝑂2   
• Superoxide dismutase (SOD) and catalase (CAT), that display an antioxidant 
activity, neutralizing excess of reactive oxygen species (ROS), such as 
superoxide (𝑂2






→  𝑂2 + 𝐻2𝑂2              2𝐻2𝑂2
𝑪𝑨𝑻
→  𝑂2 + 𝐻2𝑂 
 
Among other metal nanoparticles, PtNPs have gained huge attention in 
nanomedicine as enzymes substitutes, due to their efficiency as CAT, HRP, and 
SOD22–26. PtNPs are gradually substituting HRP and CAT in several colorimetric or 
fluorometric assays. Up to now, PtNPs-based colorimetric sensors have been 
developed for the detection of tumour markers27, metal ions, drugs28, viruses15, 
antibodies29, and small molecules3031.  
PtNPs enzymatic activity is affected by NPs size, shape, and coating. Most notably, 
it has been demonstrated that nanozyme activity scales inversely with the particle 
size. Smaller nanoparticles expose larger surface, showing higher catalytic activity 
compared to the larger ones (with the same total mass)20. It has been reported 
that PtNPs of 5 nm have higher peroxidase performance (apparent Km with H2O2 
= 47.2 mM) compared to 20 nm PtNPs26 (apparent Km with H2O2= 123.6 mM) (see 
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Figure 4.1). Moreover, recently published studies reported that the NP shape 
affects the catalytic activity32–34, drawing the scientific attention to the 
development of more controllable synthetic protocols32.  
 
 
Figure 4.1 HRP-like activity of PtNPs. (A) Time-dependent UV-visible absorption spectra at 652 nm 
of 5 nm PtNPs (red), 20 nm PtNPs (green), and HRP enzyme (blue) (ref.26) (B) Partial oxidation of 
2-propanol over PtNPs of similar size (S1-S4) but different shape. (C) Average number of broken 
bonds at the NP surface (ref 32). 
 
4.1.2 PtNPs as peroxidase-mimics 
 
In biological environment, peroxidase catalyzes the reduction of hydrogen 
peroxide, oxidizing the antioxidant molecule glutathione. 
In diagnostics, this enzyme is used in combination with chromogenic or 
fluorometric substrates (e.g., 3,3′,5,5′-tetramethylbenzidine-TMB, 2,2'-azino-
bis(3-ethylbenzothiazoline-6-sulphonic acid)-ABTS or luminol) and hydrogen 
peroxide in several assays. However, its use in POC diagnostics is restricted by 
intrinsic limitations, namely intolerance to harsh conditions and ease of 
denaturation together with the large-scale production problems and the high 
costs21. Therefore, PtNPs have been proposed to effectively replace peroxidase in 
these applications. Indeed, it has been demonstrated that PtNPs are able to 
catalyse the hydrogen peroxide dissociation in 2 radicals (𝐻𝑂.) that trigger a chain 
mechanism resulting in a two-step electron transfer for the TMB oxidation35–37 






Figure 4.2 (A) PtNPs-catalyzed TMB oxidation mechanism in the presence of H2O2. (B) UV-vis 
spectra of TMB species: consumed diamine (280 nm, black line), charge transfer complex (370 nm 
and 652 nm, blue line), and diimine (450 nm, yellow line) (ref.38). 
 
The first step leads to the 3, 3′,5 ,5′-Tetramethylbenzidine TMB radical that 
disproportionates in a blue-coloured complex, whilst the second electron transfer 
step is induced by the addition of sulfuric acid, resulting in a yellow diimine 
molecule. The reaction can be monitored by UV-vis spectrophotometric analysis: 
over the reaction progress, the TMB molecule UV peak (λ = 280 nm) decreases, 
and two new peaks appear in the visible range (λ1 = 370 nm, and λ2 = 652 nm) 
relatively to the charge transfer complex. These two peaks grow to a maximum 
during the reaction and then decay, being replaced by a peak at λ = 450 nm, 
indicating the formation of the diiminic product38,39 (see Figure 4.2 B). The PtNPs 
peroxidase-like behaviour has been extensively investigated by a kinetic study, 
confirming that PtNPs exhibit Michaelis-Menten kinetics, showing higher affinity 
to TMB compared to the natural enzyme26. 
 
4.1.3 PtNPs synthesis 
 
Chemical Reduction (WCR) represents the most commonly used PtNP synthetic 
method4041. It involves the use of a reducing agent, such as sodium borohydride 
(NaBH4), sodium citrate and ascorbic acid, to produce metallic platinum, starting 
from the Pt salt, namely hexachloroplatinic acid (H2PtCl6). The reduction rate, the 
reducing agent/ Pt salt ratio, the temperature of the reaction, and the stabilizing 
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molecules can be easily modified for the tuning of the PtNP shape and size. PtNPs 
with a diameter of 20-100 nm can be obtained by a multistep seed-mediated 
growth process42. In the first step, the nucleation phase takes place, and clusters 
of Pt (0) atoms are obtained. In a later step, the NPs growth from seeds occurs, 
leading to bigger structures.  
To meet the increasing demand for high biocompatible and surfactants-free 
PtNPs, researchers have moved their attention on “green” synthesis protocols. 
These methods are mainly based on the use of “green” reagents, such as ascorbic 
acid and trisodium citrate, and “green” solvents, such as water instead of ethylene 
glycol.43 In our laboratory, the green PtNPs synthesis was optimized to produce 
well monodispersed, flower-shaped platinum nanoparticles26. The jagged surface 
of PtNPs offers a drastically increased surface, if compared to spherical shaped 
NPs.  
 
4.1.4 PtNPs-based methods for mercury ions 
detection  
 
Aa previously discussed in Chapter 2, most of heavy metal ions are known to be 
carcinogens and highly toxic. Notably, mercury species effects on living organisms 
have been well characterized44–46. However, considering that traditional tests are 
expensive and require costly instrumentations (e.g. graphite furnace atomic 
absorption spectroscopy-GF-AAS, inductively coupled plasma-mass spectrometry-
ICP-MS, and liquid chromatograph-mass spectrometry-LC-MS)47–49, the mercury 
assessment in drinking water and food is sporadic. Therefore, the development of 
an effective mercury detection method for point-of-care applications is still a 
challenge.  
The purpose of this project was the development of a novel naked eye, rapid, and 
easy-to-use PtNPs-based mercury sensor.  
The method consists of two stages. First, mercury ions are quantitatively reduced 
using a weak reducing agent, like ascorbic acid (AA), leading to elemental mercury 
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that nucleates on the nanoparticle surface (nucleation step). Subsequently, 
residual free PtNP surface is evaluated by monitoring the TMB oxidation in the 
presence H2O2, according to the reaction reported in the Figure 4.3. 
 
 
Figure 4.3 Pt-NPs based method for the mercury detection. 
 
 
4.2 Materials and methods  
 
4.2.1 Synthesis of spherical 5 nm PtNPs 
 
Citrate-capped PtNPs with a diameter of 5 nm (Pt5) were synthesized by direct 
nucleation. 160 μL of 0.5 M H2PtCl6 were dissolved in 79.65 mL of double distilled 
water together with 192 μL of 0.5 M sodium citrate. 5.4 mL of a solution 0.06 M 
of NaBH4 were added by slow dropwise, under vigorous stirring. To remove the 
excess of reducing agent, the temperature was then raised to 75 °C. After 30 
minutes, the solution was cooled to room temperature and washed with 2 mM 
sodium citrate solution using 10K Centrifugal Filters, and stored under 4 °C. 
 
4.2.2 Synthesis of flower-like 20 nm PtNPs  
 
Citrate-capped PtNPs with a diameter of 20 nm were synthesized by a seed-growth 
method26, starting from 3 nm seeds prepared by the procedure reported by Bigall 
et al42. 3mL of this solution were added to 150 mL of double distilled water, under 
stirring, together with 216 μL of 0.5 M H2PtCl6. Subsequently, 1.5 mL of a solution 
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containing 1.25% (m/v) sodium citrate and 1% (m/v) L-ascorbic acid were added 
and the temperature was gradually raised (~ 5 °C/min) to the boiling point. The 
reaction was conducted at reflux (~ 100 °C) for 1 h. After being cooled at room 
temperature, the solution was washed with 2 mM citrate solution using 50K 
centrifuge filters to remove any contaminant. 
 
4.2.3 TEM imaging 
 
The TEM analysis was performed using a JEOL JEM 1400 microscope. Samples 
were prepared drop casting 3 μL of each solution on oxygen plasma cleaned grid 
(CF150-Cu-50 - Carbon Film 150 Mesh, Cu, 50/bx) and vacuum drying. 
 
4.2.4 UV-visible spectroscopy 
 
UV-vis spectra (400-800 nm) of the nanoparticle suspension were acquired by a 
Thermo Fisher NanoDrop® (wavelength Accuracy ± 1 nm, absorbance accuracy 3 
% at 0.74 Abs@350nm) with a small volume cuvette. PtNPs were incubated with 
positive samples obtained by adding a spike of a standard mercury solution in tap 
water. After the nucleation step, the detection mix was added and the TMB 
oxidation reaction was monitored by spectrophotometric kinetic reading. Briefly, 
5.0 μL of 200 mM citric acid/sodium citrate buffer solution (pH 5.0) were added to 
80 μL of mercury spiked water followed by 1 μL of Pt20 (125 pM in 2 mM trisodium 
citrate) or 5 μL of Pt5 (5 nM in 2 mM trisodium citrate) and 1 μL of 5 mM ascorbic 
acid solution. After 5 minutes of incubation, 20 μL of 500 mM TMB and 20 μL of 






4.2.5 X-ray Photoelectron Spectroscopy (XPS)  
The XPS analyses were carried out with a Kratos Axis Ultra spectrometer. The 
sample for XPS characterization was prepared by drop casting a few microliters of 
a 200-fold concentrated solution of PtNPs (after incubation) on a freshly cleaved 
highly oriented pyrolytic graphite (HOPG) substrate (NT-MDT, ZYB). Spectra were 
analyzed using CasaXPS software (version 2.3.17). 
 
4.3 Results  
 
4.3.1 PtNPs characterization  
 
Two sets of PtNPs have been tested to compare the behaviour of 20 nm flower-
like PtNPs and 5 nm spherical PtNPs. After the synthesis bot 5 and 20 nm PtNPs 
have been characterized in terms of size acquiring TEM images (see Figure 4.4 and 
Figure 4.5).  
 












The performance of the nanosensor is closely related to the ability to control the 
surface passivation with metallic mercury. Considering the first step of the sensing 
strategy as a heterogeneous nucleation, modulating the PtNPs shape and 
diameter, whole mercury shell can be obtained even in case of low Hg2+ 
concentrations. Our results show that 5 nm PtNPs allows a high yield amalgam 
formation which translates in higher sensitivity of the method. Figure 4.6 shows 
the comparison between 5nm PtNPs and 20 nm PtNPs in terms of residual 
peroxidase-like activity after incubation with water sample containing Hg2+ 100 
nM. 5 nm PtNPs report higher surface passivation, paired the analyte concentration 
the small slide surface favour the nucleation of the mercury ions, resulting in a 
lower Limit-Of-Detection.  
 
Figure 4.6 comparison of residual catalytic activity between spherical 5nm PtNPs and flower-like 
20 nm PtNPs after incubation with Hg2+ 100 nM. The solid surface of spherical PtNPs allows 





4.3.2 Reducing agent optimization 
 
Since the residual catalytic NP surface is inversely proportional to the Hg2+ content 
within the sample, a quantitative assessment can be achieved by modulating the 
reduction of mercury to the elemental form and the amalgam reaction. The 
method selectivity relies on the Hg2+ high Red-Ox potential (E°= 0.85) that makes 
it capable to react even in the presence of weak reducing agents. AA has been 
chosen to help the mercury reaction (E°= 0.39), whilst it cannot reduce the other 
cations naturally occurring in fresh water (K+, Na+, Ca2+, Fe2+, Cr3+ etc.), due to their 
lower redox potentials. However, AA concentration has been finely tuned, as it 
competes with TMB in the reaction with OH•, causing the delay of the TMB 
catalysed chromogenic reaction. We tested different concentrations of AA to 
obtain a suitable delay for ON/OFF colorimetric output of the sensor (see Figure 
4.7). 

























Figure 4.7 Tuning of the delay caused by increasing amounts of 5 mM AA solution. 
 
Alternative reducing agents, namely oxalic acid and formic acid, have been tested 
with the aim to obtain a complete mercury reduction in short time. Figure 4.8 
shows promising preliminary data in the presence of oxalic acid. A 100 nM 
concentration of Hg2+ can be detected without any delay typical of the AA 





Figure 4.8 Reduction using Oxalic acid as reducing agent: in 20 min, a significant PtNPs surface 
passivation occurs in the presence of a 100 nM Hg2+ spiked sample. Moreover, any delay of the 
TMB oxidation was observed. 
 
 
4.3.3 Incubation step optimization 
 
To improve the sensitivity of the method, also the incubation time was 
characterized with the aim to determine the minimum time required for effective 
nucleation. Four mercury spiked water samples (25nM-100nM) were incubated 
with PtNPs and AA, and the residual peroxidase-like activity of the nanomaterial 
was evaluated at different time-points (see Figure 4.9).  
Higher incubation times resulted in higher sensitivity of the sensor. Figure 7C 
shows that a sample containing 50 nM Hg2+ could be detected after 30 minutes of 
incubation, whilst 12 hours of incubations are needed for detecting a sample 
containing 25 nM Hg2+ (see Figure 4.9 D). The Limit-Of-Detection (LOD) for a fast 





Figure 4.9 Peroxidase-like activity of PtNPs incubated with different concentrations of Hg2+ (100-
75-50-25 nM). The TMB oxidation reaction was recorded after several incubation times: 5 min (A), 
15 min (B), and 30 min (C). Increasing the incubation time (>60 min), 25 nM Hg2+ can be detected 
with remarkable NP surface passivation (D). 
 
4.3.4 Incubation step optimization 
 
To characterize the amalgam formation during the nucleation step of the method, 
TEM images of 5 nm PtNPs were acquired before and after the reaction with Hg2+ 
and AA (Figure 4.10 A, B). NPs polydispersity increase points out the nucleation of 
metallic mercury on the particles surface. XPS analysis was performed on PtNPs 
after the incubation with water samples spiked up to 50 nM Hg2+ (PD 10,11) and 
100 nM Hg2+ (PD12,13), confirming the efficiency of the reducing agent on the 
mercury amalgam formation Figure 4.10 C). Optimizing the nucleation reaction as 
well as the TMB oxidation, a LOD of 80 nM was obtained for the detection of Hg2+ 
in real tap water. In 5 minutes, the amalgam formation on PtNPs allows a perfect 
ON/OFF read out of the results in which the negative sample has a vivid blue colour 





Figure 4.10 (A) TEM images of 5 nm PtNPs before (A) and after (B) 5 minutes of incubation with 
water sample containing 100 nM Hg2+. (C) XPs results in terms of Hg (at%) and Pt (at%) for samples 
containing 50 nM Hg2+ (PD10,11) and 100 nM Hg2+ (PD12,13), respectively (D). Time-dependent 
absorbance signals at 652 nm of TMB after incubation with H2O2 and PtNPs for a negative (Ctrl) 
and positive (Hg2+ 80 nM) sample with remarkable colorimetric ON/OFF result. 
 
In order to stabilize PtNPs in complex media, as sea water or food extracts, various 
strategies have been tested. To avoid the PtNPs precipitation during the assay, we 
adsorbed the nanomaterial on different particles as support. Commercial 
products, like AEROSIL® 150 (hydrophilic fumed silica) and 60 nm diameter Silica 
nanoparticles, are able to efficiently stabilize small nanoparticles in solution, 
proved dosing the catalytic activity, (see Figure 4.11 A, B). To validate this 
approach, the PtNPs catalytic activity was characterized before the NPs absorption 
on silica nanoparticles, as well as before and after the lyophilization procedure 
(see Figure 4.11 C). However, we observed a reduction in the method sensitivity 
in the presence of the nanosized support, due to the difficult of mercury ions to 





Figure 4.11 TEM images showing the results of PtNPs stabilization on different supports. (A) 
Lyophilized PtNPs supported on AREOSIL 150 after resuspension in water. (B) Silica NPs as support 
for 20 nm PtNPs. (C) Peroxidase-like activity comparison between citrate capped-PtNPs and PtNPs 
stabilized on Silica NPs as support, before (blue) and after (red) the lyophilization, and once 
resuspended (green). 
An interesting approach to increase PtNPs stability involves the use of polymers, 
such as Polyvinylpyrrolidone (PVP) and Poly (acrylic acid). According to these data, 
we observed that PVP coated-PtNPs can be stored as lyophilized powder and 
directly resuspended during the assay (see Figure 4.12).  
 
Figure 4.12 Comparison between citrate- and PVP-capped PtNPs: the polymer does not affect the 
nanoparticle surface reactivity allowing the same sensitivity of “naked” nanoparticles in the 
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In this work, we explored the use of PtNPs as nanozymes in surface passivation-
based colorimetric method for mercury ions detection in water samples. We 
reported easy and fast assay that in less than 10 minutes give out a remarkable 
colour change that allows the naked eye ON/OFF colorimetric assessment of 
mercury contaminations. This nanosensor shows some relevant optimizations 
compared to the other approaches previously published, as the use of stabilized 
PtNPs that enables the assessment of mercury contaminations in real samples. 
Moreover, tuning the incubation time and using different reducing agents, such as 
oxalic acid, the analytical utility of this method can be implemented. Considering 
the method features, this nanosensor can be easily transferred to solid based 
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Point-Of-Care testing is strongly improving quality-of-life, providing new 
diagnostic solutions for both healthcare systems and environmental control. In 
this framework, this project has been centred on the development of three 
nanoparticles-based sensors for the easy and rapid assessment of analytes of 
biomedical and environmental interest, taking advantage of enzymatic and 
plasmonic nanoparticles properties.  
The first aim of this work has been the development of a self-catalysed plasmonic 
platform for the methyl mercury detection in organic samples, such as human 
urine and food extracts. Mercury, as well as other heavy metal ions, is ranked in 
the top ten list of hazardous substances, due to its toxic effects on both human 
and environmental health. To date, the mercury assessment is sporadic, as the 
tests are laborious and expensive. The proposed nanosensor combine catalytic 
and plasmonic properties of gold nanoparticles to achieve fast organic mercury 
detection with high sensitivity. To the best of our knowledge, this technique 
represents the first easy-to-use platform for the detection of organic mercury in 
biological fluids and food extracts, as a marker of mercury intoxication and 
contaminations.  
Furthermore, plasmonic properties applications are not limited to classical 
aggregation-based colorimetric methods. Gold nanoparticles size and shape can 
be finely manipulated in a new class of sensors that respond to external stimuli, as 
the analytes, leading to a colorimetric outcome. 
Therefore, as second aim of this work, the surface reshaping process of gold 
multibranched nanoparticles has been exploited to develop a customizable 
method for glucose measurement in saliva. Combining the target enzymatic 
conversion and the gold nanoparticles reshaping in a boosted color change 
outcome, a new and effective nanobiosensor for the salivary glucose assessment, 
with micromolar sensitivity, has been developed. This nanoparticle-based 
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technology has been successfully transferred into an integrated -Pad and applied 
for the fast ad non-invasive salivary glucose assessment in real diabetic patient 
samples. The obtained results show that this innovative platform represents a 
valid alternative to the invasive, and eventually painful, blood tests. 
In the last part of this work, I have reported an enzymatic method based on 
platinum nanoparticles for the measurement of the mercury content in water 
samples. The sensor relies on the reduce mercury amalgam formation on the 
particles surface and its subsequent colorimetric quantification, providing a simple 
and rapid (10 minutes) method for instrument-free water mercury assessment.  
In conclusion, during my thesis work, I have explored the peculiar properties of 
gold and platinum nanoparticles to develop a set of nanobiosensors, in order to 
overcome the drawbacks of traditional diagnostic techniques. Providing solutions 
for real applications, these Point-Of-Care devices will be soon a market reality, as 
new approaches to portable diagnostics.   
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